Indian Patents
Title of Invention

CRYSTALLOGRAPHICALLY STABLE AMORPHOUS CEPHALOSPORIN COMPOSITIONS AND PROCESS FOR PRODUCING THE SAME.
Abstract TITLE: CRYSTALLOGRAPHICALLY STABLE AMORPHOUS CEPHALOSPORIN COMPOSITIONS AND PROCESS FOR PRODUCING THE SAME. Processes are provided for the preparation of orally administrable, yellow and powdert compositions essentially consisting of particles composed of a homogeneous mixture of an amorphous cefditoren pivoxil substance with a water soluble high-molecular additive. These compositions can be produced by dissolving crystalline cedfitoen pivoxil substance and the water-soluble high-molecular additive in an aqueous solution of an acid, then neutralizing the resultant solution, to co-precipitate the product, and drying the thus precipitated product, followed by recovering the product in the form of the above-mentioned particles.
Full Text DESCRIPTION
A composition comprising a crystallographically stable,
amorphous cephalosporin and processes for the preparation
thereof
Technical Field
This invention relates to an orally administrable and
powdery composition consisting essentially of a number of
particles each comprising a crystallographically stable and
amorphous cephalosporin. More specifically, this invention
relates to a novel, orally administrable and powdery
composition consisting essentially of particles which each
have a uniform internal texture within each particle and each
are formed from a homogeneous mixture of an amorphous and
water-soluble substance of 7-[(Z)-2-(2-aminothiazol-4-yl)
-2-methoxyiminoacetamido]-3-[(Z)-2-(4-methylthiazol-5-yl)
ethenyl]-3-cephem-4-carboxylic acid pivaloyloxymethyl ester,
that is, Cefditoren pivoxil (a generic name), with a water-
soluble, high-molecular additive, for example, a water-
solubilized derivative of cellulose. This invention further
relates to processes for the preparation of the novel, orally
administrable and powdery composition as above-mentioned.
Background Art:
The cephem compound known under the generic name
"cefditoren" is the compound which is represented by the
following formula (A)
and which compound was at first named as 7-[2-
methoxyimino-2-(2-aminothiazol-4-yl)acetamido]-3-[2-(4-
methylthiazol-5-yl)vinyl]-3-cephem-4-carboxylic acid
(syn-isomer, cis-isomer) (refer to Japanese Patent
Publication Hei 3-64503 specification, United States Patent
No.4,839,350 and European Patent No.0175610 specification).
Cefditoren pivaloyloxymethyl ester is a pharmacitical substance
known under the generic name "Cefditoren pivoxil" and is the
compound represented by the following formula (B)
Cefditoren pivoxil is also known in the name of "(-)-(6R,7R)
-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]
-3-[(Z)-2-(4-methylthiazol-5-yl)ethenyl]-8-oxo-5-thia-l-
azabicyclo[4.2.0] oct-2-ene-2-carboxylic acid 2,2-
dimethylpropionyloxymethyl ester" and is described on page
317 of the literature "Merck Index", the 12th Edition to be
a pale yellow-colored powdery substance melting at 127~129°C.
Another chemical name of the compound "Cefditoren pivoxil"
is 7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]
-3-[(z)-2-(4-methylthiazol-5-yl)ethenyl]-3-cephem-4-
carboxylic acid pivaloyloxymethyl ester.
Cefditoren pivoxil, when orally administered, can be
well absorbed by the digestive tracts, within which Cefditoren
pivoxil is hydrolyzed into Cefditoren. It is known that
Cefditoren is an antibiotic substance possessing an extremely
broad antibacterial spectrum but a low toxicity and Cefditoren
is very excellently useful for the therapeutic treatment and
prevention of diseases which are caused by gram-positive and
gram-negative bacteria. At present, Cefditoren pivoxil is

widely utilized as an orally administrable pharmacitical substance for the
therapy.
We, the present inventors, had made investigations
with the intention of obtaining a highly pure product of
Cefditoren pivoxil, and as a result, we already succeeded
in obtaining Cefditoren pivoxil in the form of an
orthorhombic crystalline substance (at a purity of: 97~
98 %) of a melting point of 206 ~ 215.7 °C (with
decomposition), by adopting a certain particular process
(refer to International Open-Laying Publication No.
W098/12200 of PCT application No. PCT/JP97/03340, issued on
March 26, 1998). This orthorhombic crystalline substance
of Cefditoren pivoxil shows such advantages that it has a
high purity, a high thermal stability and a high storage-
stability under high-humidity conditions , but still it shows
such disadvantage that it itself is not so suitable for the
purpose of oral administrations due to its poor solubility
in water.
Disclosure of Invention
In general, for such medicinal compounds which are
sparingly soluble in water, it is well known that the
solubility or the dissolution speed of the sparingly
water-soluble compounds in water can exert a great influence
on the absorption in vivo of said compounds. Thus, many
reports were presented on how to improve the water-solubility
of such medicinal compounds which are sparingly soluble in
water. One of the reported proposals is a method in which a
medicinal compound sparingly soluble in water is converted
into an amorphous substance, thus to improve the solubility
of the compound in water. It is known that an amorphous
substance generally has a higher solubility in water, as
compared with that of the corresponding crystalline substance.
It is therefore expectable that if the orthorhombic
crystalline substance of Cefditoren pivoxil sparingly soluble
in water is converted into an amorphous substance which is
of a higher solubility in water, there may be afforded such
a water-soluble and highly pure product of Cefditoren pivoxil
which is capable of exhibiting its therapeutic efficacy to
a full extent.
We have therefore further prosecuted diligently our
investigations in order to solve the problem of convertinq the
crystalline Cefditoren pivoxil into an amorphous substance
having a higher water-solubility. As a result, we have now
found that there can successfully be prepared an orally
administrable, yellow-colored powdery composition consisting
essentially of such particles which each have a uniform
internal texture or tissue within each particle and which each
are formed from a homogeneous mixture of the amorphous
Cefditoren pivoxil substance having a high water-solubility
and a high thermal stability, with a water-soluble high-
molecular additive, when use is made of such a process which
comprises dissolving a crystalline Cefditoren pivoxil in an
acidic aqueous solution containing a water-soluble high-
molecular additive, for example, a water-solubilized
derivative of cellulose and an acid dissolved therein, thereby
to form an acidic aqueous solution containing Cefditoren
pivoxil, the water-soluble high-molecular additive and the
acid dissolved therein, then slowly adding to the resultant
acidic aqueous solution an aqueous solution of an inorganic
base to neutralize said acidic aqueous solution to a neutral
or a substantially neutral pH value, with co-precipitating
Cefditoren pivoxil and said water-soluble high-molecular
additive simultaneously from said aqueous solution during the
neutralization operation, then washing the deposited
precipitate with an aqueous solution of the water-soluble
high-molecular additive, drying the washed precipitate, and
recovering the resulting particulate product so dried. This
invention has been established on the basis of these findings
mentioned above.
Thus, according to a first aspect of this invention,
there is provided an orally administrable, yellow-colored
powdery composition consisting essentially of solid particles
which each are formed of a homogeneous mixture of a crystallo-
graphically stable, amorphous and water-soluble substance of
Cefditoren pivoxil with a water-soluble high-molecular
additive, and which particles have a uniform, internal texture
within each particle, characterized in that said yellow-
colored powdery composition consists essentially of the solid
particles each formed of the homogeneous mixture of (i) the
crystallographically stable, amorphous and water-soluble
substance of Cefditoren pivoxil, namely 7-[(Z)-2-(2-
aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-[(Z)-2-(4-
methylthiazol-5-yl)ethenyl]-3-cephem-4-carboxylic acid
pivaloyloxymethyl ester, with (ii) the water-soluble high-
molecular additive which is either such a pharmaceutically
acceptable, water-solubilized derivative of cellulose as
chosen from hydroxypropylmethyl cellulose, hydroxypropyl-
methyl cellulose phthalate, hydroxypropyl cellulose, methyl
cellulose and a pharmaceutically acceptable alkali metal salt
or alkaline earth metal salt of carboxymethyl cellulose, or
pluran, carrageenan, polyvinylpyrrolidone or an alginic acid
ester of polypropylene glycol, that the water-soluble
high-molecular additive (ii) contained in the above-mentioned
solid particles is present in said particles in a proportion
of 0.5 % ~ 5 % based on the weight of the Cefditoren pivoxil
substance, that said particles fuse at a temperature of 120 °C
or higher, but do not show any definite melting point, that
the amorphous substance of Cefditoren pivoxil (i) contained
in said particles does not show any peak of the angle of
diffraction in a X-ray powder diffractometry chart of said
particles but exhibits in its infrared absorption spectrum
(as measured by pelleted potassium bromide method) a
substantially broader peak of absorption at a wave number of
1750 cm-1, as compared with the sharp peak of absorption
exhibited by the orthorhombic crystalline substance of
Cefditoren pivoxil at a wave number of 1750 cm-1 in the infra-
red absorption spectrum, and that the amorphous substance of
Cefditoren pivoxil (i) contained in said particles can be
dissolved in an acidified water containing hydrochloric acid
(pH 1.2) at a solubility of at least 4 mg/ml of Cefditoren
pivoxil at 37 °C and has a crystallographical stability such
that said amorphous Cefditoren pivoxil substance does not
involve crystallization when stored at 40 °C for 4 months in
a sealed container under dry conditions.
One preferred example of the powdery composition
according to the first aspect of this invention is such a
composition consisting essentially of particles each formed
of a homogeneous mixture of a crystallographically stable,
amorphous and water-soluble substance of Cefditoren pivoxil
with the water-soluble high-molecular additive which is
hydroxypropylmethyl cellulose, hydroxypropyl cellulose,
methyl cellulose or polyvinylpyrrolidone, and which additive
as blended is present in a proportion of 1 % ~ 3 % based on
the weight of the Cefditoren pivoxil.
Further, in respect of the respective solid particles
which each are formed of the homogeneous mixture of the
amorphous Cefditoren pivoxil with the water-soluble high-
molecular additive and which are present in the powdery
composition according to the first aspect of this invention,
we have now observed, under a polarizing microscope of 400
magnifications or under an electron microscope, the surface
texture or tissue of said solid particles, and we have found
that the surface of each particle has a simple and uniform
texture or tissue. We cannot find any presence of independent
and separate grains of either Cefditoren pivoxil or the
high-molecular additive in the surface of each particle.
In the powdery composition according to the first
aspect of this invention, the water-soluble high-molecular
additive which is to be mixed with the amorphous Cefditoren
pivoxil, and which is the water-solubilized cellulose
derivatives, or pluran, carrageenan, polyvinylpyrrolidone or
an arginic acid ester of polypropylene glycol, may be of a
grade thereof which usually is used and incorporated in the
formulations of medicines as a binder or a suspending agent.
Among the water-soluble high-molecular additives to be usable
in the composition of the first aspect of this invention, the
water-solubilized derivatives of cellulose are particularly
preferred. As the water-solubilized derivatives of cellulose,
there may be used hydroxypropylmethyl cellulose (abbreviated
as HPMC), hydroxypropylmethyl cellulose phthalate (abbreviated
as HPMCP), hydroxypropyl cellulose (abbreviated as HPC), methyl
cellulose (abbreviated as MC), carboxymethyl cellulose
calcium salt or carboxymethyl cellulose sodium salt. The use
of hydroxypropylmethyl cellulose (HPMC), hydroxypropyl
cellulose (HPC) or methyl cellulose (MC) is particularly
preferred.
In the homogeneous mixture which constitutes the
solid particles present in the powdery composition of the first
aspect of this invention, and which is composed of the
amorphous Cefditoren pivoxil and the water-soluble high-
molecular additive, the proportion of the water-soluble high-
molecular additive to be incorporated therein may be in a range
of 0.5 % ~ 5 %, preferably in a range of 1 % ~ 3 % based on
the weight of Cefditoren pivoxil.
Further, we have tried to measure the melting point
of the solid particles present in the composition of the first
aspect of this invention, by placing the particles in a melting
point-measuring apparatus. As a result, we have found that
these solid particles fuse at 120 ~ 150 °C with decomposition,
but do not show any one definite melting point.
We have further carried out the measurement of powder
X-ray diffraction of the solid particles present in the
composition of the first aspect of this invention, by placing
the particles in a X-ray powder diffraction apparatus (Rigaku
Denki K. K. : Geigerflex 2027) . Upon analysis of the pattern
of the resulting X-ray diffraction chart of said X-ray powder
diffraction, it is shown that no peak is appearing in the angle
of diffraction, indicating that the Cefditoren pivoxil
substance existing in said solid particles is amorphous in
nature.
We have further carried out a measurement of infrared
absorption spectrum of the solid particles present in the
composition of the first aspect of this invention, by mixing
the solid particles with an amount of potassium bromide,
compressing the resultant mixture to pelletize the same, and
then placing the resulting pellet into an infrared absorption
spectrometer. In the spectrum chart thus obtained, the
infrared absorption spectrum of the Cefditoren pivoxil
substance present in said powder exhibits at a wave number
of 1750 cm"1 an absorption peak which is substantially broader
than such a sharp absorption peak that the orthorhombic
crystalline substance of Cefditoren pivoxil exhibits at a wave
number of 1750 cm"1 in its infrared absorption spectrum.
We have also made a measurement of powder X-ray
diffraction of the previously stored solid particles present
in the composition of the first aspect of this invention, by
placing and storing said solid particles in a sealed container
under a dry air atmosphere at 40 °C for 4 months, followed by
measuring the powder X-ray diffraction of the stored particles
in the powder X-ray diffraction apparatus used as above.
Analysis of the pattern of the resulting powder X-ray
diffraction chart did not indicate any peak in the angle of
diffraction in the chart. Thus, it is demonstrated that the
Cefditoren pivoxil present in the particles stored as above
has remained in the amorphous state and that it is
crystallographically stable and can maintain the amorphous
state even after the storage thereof for a long period of time.
We presume that in the composition of this invention,
the water-soluble high-molecular additive co-existent in
admixture with the Cefditoren pivoxil in the solid particles
can possess a function capable of inhibiting the molecules
of Cefditoren pivoxil from undergoing their crystalli-
zation.
The solid particles present in the composition of this
invention have an average particle diameter within the range
of 0.5 µ ~ 100 µ.
The solid particles present in the composition of this
invention were tested for the measurement of their water-
solubility as shown in Test Example given hereinafter. It was
thus found that the amorphous Cefditoren pivoxil contained
in said particles was soluble in an acidified water of pH 1.2
containing about 0.1 N hydrochloric acid (corresponding to the
artificial gastric juice specified in Japanese Pharmacopedia)
and had a solubility of at least 4 mg/ml in the acidified water
at 37 °C.
Furthermore, we have proceeded our further
investigation. Thus, when we carry out, for the purpose of
producing the particles of the powdery composition of the first
aspect invention, the process which comprises the steps of
completely dissolving a crystalline Cefditoren pivoxil in an
acidic aqueous solution containing and having dissolved
therein a water-soluble high- molecular additive and an acid,
thereby to prepare an acidic aqueous solution containing
Cefditoren pivoxil, the water- soluble high-molecular
additive and the acid all dissolved therein, then slowly adding
to the resulting acidic aqueous solution so prepared an aqueous
solution of an inorganic base, thereby to neutralize the acidic
aqueous solution to a neutral pH value or a substantially
neutral pH value, allowing, during the neutralization
operation, Cefditoren pivoxil and the first-mentioned
water-soluble high-molecular additive to co-precipitate
simultaneously from said aqueous acidic solution, separating
and then washing the deposited precipitate with an aqueous
solution of the first-mentioned a water-soluble high-
molecular additive and subsequently drying the washed
precipitate, we have now found that the aforesaid process can
be carried out in such one modified manner that the first
mentioned water-soluble high-molecular additive, which was
contained in said acidic aqueous solution of the water-soluble
high-molecular additive and the acid to be employed for the
dissolution of Cefditoren pivoxil, and which is to be contained
in the washing aqueous solution of the high-molecular additive
for washing the deposited precipitate, is replaced by such
a second, water-soluble high-molecular additive which is made
of a compound different from said first-mentioned high-
molecular additive, when it is intended to prepare a washing
aqueous solution of the water-soluble high-molecular additive
which is to be employed in the step of washing said deposited
precipitate therewith, and thereby at least a portion of the
second, water-soluble high-molecular additive present in so
prepared the washing aqueous solution of the second additive
as employed for the aforesaid washing step is allowed to
transfer into the surface of the precipitate particles during
said washing step. It has further been found that, when said
washing step is conducted with said aqueous solution of the
second-mentioned additive, followed by conducting the steps
of recovering and drying the precipitate particles of which
the surface have contained therein the second, water-soluble
high-molecular additive as transferred from the washing
aqueous solution employed in said washing step, there can be
afforded such dried precipitate particles wherein the surface
layer of each of said solid particles as collected is formed
from a homogeneous mixture of the amorphous Cefditoren pivoxil
with the first, water-soluble high-molecular additive and the
second, water-soluble high-molecular additive, but wherein
the central portion or core portion of each of the solid
particles lying under the surface layer of the solid particles
is formed from a homogeneous mixture of the amorphous
Cefditoren pivoxil with the first, water-soluble high-
molecular additive.
According to a second aspect of this invention,
therefore, there is provided an orally administrable, yellow-
colored powdery composition consisting essentially of
particles which each substantially comprise mixtures of a
crystallographically stable, amorphous and water-soluble
substance of Cefditoren pivoxil with water-soluble high-
molecular additive or additives, and which particles have a
uniform, internal texture within each particle, characterized
in that the yellow-colored powdery composition consists
essentially of the particles each substantially comprising
a mixture of (i) the crystallographically stable, amorphous
and water-soluble substance of Cefditoren pivoxil, namely
7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-
3-[(Z)-2-(4-methylthiazol-5-yl)ethenyl]-3-cephem-4-
carboxylic acid pivaloyloxymethyl ester, with (ii) a first,
water-soluble high-molecular additive which is either such
a pharmaceutically acceptable, water-solubilized derivative
of cellulose as chosen from hydroxypropylmethyl cellulose,
hydroxypropylmethyl cellulose phthalate, hydroxypropyl
cellulose, methyl cellulose and a pharmaceutically acceptable
alkali metal salt or alkaline earth metal salt of carboxymethyl
cellulose, or pluran, carrageenan, polyvinylpyrrolidone or
an alginic acid ester of polypropylene glycol, that the central
portion or core portion of the respective particles which is
lying under the surface layer of said respective particles
is formed only from a homogeneous mixture of (i) the amorphous
substance of Cefditoren pivoxil with (ii) the above-mentioned
first, water-soluble high-molecular additive, but the surface
layer of said particles is formed from a homogeneous mixture
of (i) the amorphous substance of Cefditoren pivoxil with (ii)
the first, water-soluble high-molecular additive and also with
(iii) such a second, water-soluble high-molecular additive
which is additionally incorporated and which second additive
is made of a substance different from the above-mentioned first,
water-soluble high-molecular additive present just in the
central portion or core portion of said particles lying under
said surface layer of the particle, and which second,
water-soluble high-molecular additive is selected from
hydroxypropylmethyl cellulose, hydroxypropyl cellulose,
methyl cellulose and polyvinylpyrrolidone, that both the first,
water-soluble high-molecular additive (ii) and the second,
water-soluble high-molecular additive (iii) are present in
a total proportion of them of 0.5 % ~ 5 % based on the weight
of the Cefditoren pivoxil substance contained in said
particles, that said particles fuse at a temperature of 120 °C
or higher, but do not show any definite melting point, that
the amorphous substance of Cefditoren pivoxil (i) contained
in said particles does not show any peak of the angle of
diffraction in a powder X-ray diffractometry chart of said
particles but exhibits in its infrared absorption spectrum
(as measured by pelleted potassium bromide method) a
substantially broader peak of absorption at a wave number of
1750 cm"1, as compared with the sharp peak of absorption
exhibited by the ortho-rhombic crystalline substance of
Cefditoren pivoxil at a wave number of 1750 cm-1 in the infrared
absorption spectrum, and that the amorphous substance of
Cefditoren pivoxil (i) contained in said particles can be
dissolved in an acidified water containing hydrochloric acid
(pH 1.2) at a solubility of at least 4 mg/ml of Cefditoren
pivoxil at 37 °C and has a crystallographical stability such
that said amorphous Cefditoren pivoxil substance does not
the particles constituting the composition, which is lying
under the surface layer of the particles, is formed from a
homogeneous mixture of the amorphous substance of Cefditoren
pivoxil with methyl cellulose, but the surface layer of said
particles is formed from a homogeneous mixture of the amorphous
substance of Cefditoren pivoxil with methyl cellulose and also
with hydroxypropylmethyl cellulose or hydroxypropyl
cellulose.
A fourth preferred example of the powdery composition
according to the second aspect of this invention is such a
composition, wherein the central portion or core portion of
the particles constituting the composition, which is lying
under the surface layer of the particles, is formed from a
homogeneous mixture of the amorphous substance of Cefditoren
pivoxil with polyvinylpyrrolidone, but the surface layer of
said particles is formed from a homogeneous mixture of the
amorphous substance of Cefditoren pivoxil with
polyvinylpyrrolidone and also with hydroxypropylmethyl
cellulose or hydroxypropyl cellulose or methyl cellulose.
The solid particles present in the composition of the
second aspect of this invention have physical and
physicochemical properties substantially the same as those
of the solid particles present in the composition according
to the first aspect of this invention.
Besides, the solid particles present in the
composition according to the second aspect of this invention
have been found to be such those that, when the surface of
the particles are observed under a polarizing microscope or
under an electron microscope, said surface has a simple and
uniform, internal texture in each particle and does not
substantially contain any independently separate grains of
Cefditoren pivoxil, nor any independently separate grains of
the water- soluble high-molecular additives in the surface
texture or tissue of said particles.
Both of the powdery composition according to the first
aspect of this invention and the powdery composition according
to the second aspect of this invention are orally administrable,
and they may be formulated in the form of tablets by blending
said composition with excipient(s), for example, starch or
talc, and/or binder (s), for example, gelatine or hydroxypropyl
cellulose, and a suitable additive agent, and then compressing
the resulting blend into tablets. Both of the powdery
compositions according to the first and second aspects of this
invention may also be formulated in the form of powdery
preparations by blending such composition with a
pharmaceutically acceptable powdery carrier, for example,
starch or cellulose powder.
For a process for the preparation of the powdery
composition according to the first aspect of this invention,
there is provided, according to a third aspect of this
invention, a process for the preparation of a yellow-colored
powdery composition consisting essentially of particles which
each are formed of a homogeneous mixture of a
crystallographically stable, amorphous and water-soluble
substance of Cefditoren pivoxil with a water-soluble high-
molecular additive, and which particles have a uniform,
internal texture within each particle, characterized in that
the process comprises a step of dissolving an orthorhombic
crystalline substance of Cefditoren pivoxil, namely 7-[ (Z )-2-
(2-aminothiazol-4-yl) -2-inethoxyiminoacetamido] -3- [ (Z }-2-
(4-methylthiazol-5-yl)ethenyl]-3-cephem-4-carboxylic acid
pivaloyloxymethyl ester, in an acidic aqueous solution which
is containing a water-soluble high-molecular additive made
of either such a water-solubilized derivative of cellulose
as chosen from hydroxypropylmethyl cellulose,
hydroxypropylmethyl cellulose phthalate, hydroxypropyl
cellulose, methyl cellulose and a pharmaceutically acceptable
alkali metal salt or alkaline earth metal salt of carboxymethyl
cellulose, or pluran, carrageenan, polyvinylpyrrolidone or
an alginic acid ester of polypropylene glycol as dissolved
at a concentration of 0.05 % to 1 % (weight/weight basis),
and which acidic aqueous solution is containing also
hydrochloric acid, phosphoric acid, sulfuric acid, acetic acid,
propionic acid or butyric acid at a concentration of 0.1N ~
12N of the acid, so that the amount of Cefditoren pivoxil
dissolved in said acidic aqueous solution is in the range of
10 times to 130 times based on the whole weight of said
water-soluble high-molecular additive contained in said
acidic aqueous solution, and so that there is prepared an
acidic aqueous solution containing Cefditoren pivoxil, the
water-soluble high-molecular additive and the acid dissolved
therein; a step of subsequently neutralizing the acidic
aqueous solution so prepared by adding slowly thereto an
aqueous solution or solutions of sodium or potassium hydroxide,
sodium or potassium hydrogen carbonate, or sodium or potassium
carbonate, singly or in combination, or an aqueous solution
of ammonium hydroxide, with maintaining said acidic aqueous
solution at a temperature of 10 °C or below under stirring,
and with the amount of the basic sodium or potassium compound
or ammonium hydroxide to be added to said acidic aqueous
solution being so adjusted that the resulting reaction
solution after the neutralization shows a pH value of 6.5 ~
7.1; and a step of continuing during the neutralization
reaction the stirring of the aqueous solution containing
Cefditoren pivoxil at a temperature of 10 °C or below, to bring
about co-precipitation of Cefditoren pivoxil and the
water-soluble high-molecular additive simultaneously from
the aqueous solution; a step of collecting by filtration or
centrifugation, the so deposited precipitate from the
resulting neutralization reaction mixture; a step of washing
the collected precipitate with an aqueous solution of a
water-soluble high-molecular additive made of the same
substance as that of the first-mentioned water-soluble
high-molecular additive and containing said additive
dissolved in said solution at a concentration of 0.5 % ~ 10 %
(weight/ weight basis), while at least a portion of said
water-soluble high-molecular additive used here in the washing
aqueous solution is allowed during the washing operation to
transfer from the washing aqueous solution of the water-
soluble high-molecular additive into the surfaces of the
particles of said precipitate; and a step of then drying the
washed precipitate, to afford the yellow-colored powdery
composition consisting essentially of the particles each
formed of the homogeneous mixture of the crystallographically
stable, amorphous and water-soluble substance of Cefditoren
pivoxil with the above-mentioned water-soluble high-
molecular additive present in a proportion of 0.5 % ~ 5 % based
on the weight of the Cefditoren pivoxil substance.
In practicing the process of the third aspect of this
invention, the acid present in the aqueous solution of the
water-soluble high-molecular additive and the acid to be used
for the dissolution of the crystalline Cefditoren pivoxil
substance may preferably be hydrochloric acid, phosphoric acid,
acetic acid or sulfuric acid. Particularly, hydrochloric
acid is preferred. The concentration of the acid in said
aqueous solution may be within a range of 0.1N ~ 12N, with
a range of 0.5N ~ 2.0N being particularly preferred.
The step of dissolving the crystalline Cefditoren
pivoxil substance in the acidic aqueous solution containing
said water-soluble high-molecular additive and acid may
preferably be carried out at a temperature of 10 °C or lower.
The dissolution of the crystalline Cefditoren pivoxil
substance may preferably be effected with taking a period of
time of 10 ~ 60 minutes therefor. By adopting these operation
conditions, it is necessary to make the Cefditoren pivoxil
substance dissolved completely in the aqueous solution of the
water-soluble high-molecular additive and the acid.
Next, there is effected the step of neutralizing the
resulting aqueous solution of the Cefditoren pivoxil, water-
soluble high-molecular additive and acid, with an inorganic
base. The aqueous solution of an inorganic base used for this
neutralization step may preferably be an aqueous ammonium
hydroxide solution, namely aqueous ammonia, or aqueous sodium
hydroxide solution, aqueous potassium hydroxide solution,
aqueous sodium hydrogen carbonate solution or aqueous
potassium hydrogen carbonate solution. Aqueous ammonia is
particularly preferred. The concentration of the inorganic
base in the aqueous solution of the inorganic base may be in
a range of 0.1N ~ 14N, but the base concentration in a range
of 0.5N~ 2 .0N is particularly preferred. An aqueous solution
of one inorganic base may be used in combination with an aqueous
solution of another inorganic base. The addition of the
aqueous solution of the inorganic base is preferably carried
out slowly, while maintaining the neutralization reaction
mixture at a temperature of 0 °C ~ 10 °C. The addition may
preferably be effected dropwise. The time to be taken for the
neutralization reaction may be 5 minutes ~ 24 hours and
preferably 5 minutes ~ 10 hours. During the neutralization
reaction, it is preferred that the amount of the inorganic
base added is so controlled that the resulting reaction mixture
shows a pH value of 6.5 ~ 7.0 at the completion of the
neutralization. With the progress of the neutralization
reaction, Cefditoren pivoxil and the water-soluble high-
molecular additive are allowed to be co-precipitated
simultaneously from the aqueous solution, resulting in the
deposition of solid precipitate. This precipitate is
composed of a mixture of Cefditoren pivoxil with the
water-soluble high-molecular additive.
After the completion of the neutralization reaction,
the precipitate is then collected from the resulting
neutralization reaction mixture. The collection of the
precipitate may be effected by filtration, for example,
filtration under a reduced pressure, or by centrifugation,
in a conventional manner.
Next, the precipitate so collected is subjected to the
step of washing it at a temperature of 10 °C or below with an
aqueous solution containing such a water-soluble high-
molecular additive which is of the same compound as the high-
molecular additive just co-precipitated and thus included in
said precipitate and which high-molecular additive is present
at a concentration of 0.5 % ~ 10 % (weight %) in said aqueous
solution. By this washing operation, the salts having
attached to the precipitate can be removed, and at least a
portion of the water-soluble high-molecular additive present
in the washing aqueous solution is allowed to transfer into
the surface of the precipitate particles from the washing
aqueous solution of the water-soluble high-molecular additive
during the washing operation. If a plain water were used for
the step of washing the precipitate, a portion of the
water-soluble high-molecular additive which has been included
and contained in the precipitate could be washed away therefrom.
In such a possible case, the particles of the powder which
could be obtained after a drying of the precipitate so washed
with the plain water would be undesirable as the target product
wanted, because the content of the water-soluble high-
molecular additive in the particles should be unsuitably lower
than the desirable one. Such undesirable product is
inappropriate in that the Cefditoren pivoxil component
contained therein can show some tendency to crystallize out.
The precipitate which has received the washing step
as above is then dried in a conventional way. The drying step
is preferably carried out at a temperature of 30 °C or lower
under a reduced pressure. Thus, as the dried final product,
there can be afforded a powdery composition consisting
essentially of solid particles which each are formed of a
homogeneous mixture of a crystallographically stable,
amorphous and water-soluble substance of Cefditoren pivoxil
and the water-soluble high-molecular additive as mixed in a
proportion of 0.5 % ~ 5 % (weight %) of said additive, based
on the weight of the Cefditoren pivoxil substance.
Preferably, the process of the third aspect of this
invention may be effected by such a process comprising a step
of dissolving the orthorhombic crystalline substance of
Cefditoren pivoxil in an acidic agueous solution which is
containing such a water-soluble high-molecular additive as
chosen from hydroxypropylmethyl cellulose, hydroxypropyl
cellulose, methyl cellulose and polyvinylpyrrolidone as
dissolved at a concentration of 0.05 % to 1 % (weight/weight
basis) and which acidic aqueous solution is containing also
hydrochloric acid or phosphoric acid at a concentration of
0.5N ~ 2.0N of the acid, so that the amount of Cefditoren
pivoxil dissolved in said acidic aqueous solution is in a range
of 10 times to 100 times based on the whole weight of said
water-soluble high-molecular additive contained in said
acidic aqueous solution, and so that there is prepared an
acidic aqueous solution containing Cefditoren pivoxil, the
water soluble high-molecular additive and the acid dissolved
therein; a step of subsequently neutralizing the so prepared
acidic aqueous solution containing Cefditoren pivoxil, by
adding slowly thereto a 1N ~ 2N aqueous sodium hydroxide
solution or/and a 1N ~ 2N aqueous sodium hydrogen carbonate
solution, or by adding slowly thereto a 1N ~ 2N aqueous
ammonium hydroxide solution, with maintaining said acidic
aqueous solution at a temperature of 5 °C or below under
stirring, until said acidic aqueous solution is neutralized
to a pH value of 6.5 ~ 7.0; a step of continuing during the
neutralization reaction the stirring of the resulting
neutralization reaction mixture at a temperature of 5 °C or
below, to bring about co-precipitation of Cefditoren pivoxil
and the water-soluble high-molecular additive simultaneously
from said aqueous solution; a step of collecting the so
deposited precipitate from the resulting neutralization
reaction mixture; a step of washing the collected precipitate
with an aqueous solution of a water-soluble high-molecular
additive made of the substance same as that of the first-
mentioned water-soluble high-molecular additive and
containing said additive dissolved in said solution at a
concentration of 0.5 % ~ 10 % (weight/weight basis); and a
step of then drying the washed precipitate, to afford the
yellow-colored powdery composition consisting essentially of
the particles each formed of a homogeneous mixture of the
amorphous substance of Cefditoren pivoxil with the above-
mentioned water-soluble high-molecular additive present in
a proportion of 1 % ~ 3 % based on the weight of the Cefditoren
pivoxil substance.
For a process for the preparation of the powdery
composition of the second aspect of this invention, there is
provided, according to a fourth aspect of this invention, a
process for the preparation of a yellow-colored powdery
composition consisting essentially of particles which each
comprise mixtures of a crystallographically stable, amorphous
and water-soluble substance of Cefditoren pivoxil with
water-soluble high-molecular additive or additives, and which
particles have a uniform, internal texture within each
particle, characterized in that the process comprises a step
of dissolving an orthorhombic substance of Cefditoren pivoxil
in an acidic aqueous solution which is containing a first
water-soluble high-molecular additive made of either such a
water-solubilized derivative of cellulose as chosen from
hydroxy-propylmethyl cellulose, hydroxypropylmethyl
cellulose phthalate, hydroxypropyl cellulose, methyl
cellulose and a pharmaceutically acceptable alkali metal salt
or alkaline earth metal salt of carboxymethyl cellulose, or
pluran, carrageenan, polyvinylpyrrolidone or an alginic acid
ester of polypropylene glycol as dissolved at a concentration
of 0.05 % ~ 1 % (weight/weight basis) and which acidic aqueous
solution is containing also hydrochloric acid, phosphoric acid,
sulfuric acid, acetic acid, propionic acid or butyric acid
at a concentration of 0.1N ~ 12N of the acid, so that the amount
of Cefditoren pivoxil dissolved in said acidic aqueous
solution is in a range of 10 times to 130 times based on the
whole weight of said first water-soluble high-molecular
additive contained in said acidic aqueous solution, and so
that there is prepared an acidic aqueous solution containing
Cefditoren pivoxil, the first, water-soluble high-molecular
additive and the acid dissolved therein; a step of subsequently
neutralizing the so prepared acidic aqueous solution, by
adding slowly thereto an aqueous solution or solutions of
sodium or potassium hydroxide, sodium or potassium hydrogen
carbonate, or sodium or potassium carbonate, singly or in
combination, or by adding slowly thereto an aqueous solution
of ammonium hydroxide, with maintaining said acidic aqueous
solution at a temperature of 10 °C or below under stirring,
and with the amount of the basic sodium or potassium compound
or ammonium hydroxide to be added to said acidic aqueous
solution being so adjusted that the reaction solution after
the neutralization shows a pH value of 6.5 ~ 7.1; a step of
continuing during the neutralization reaction the stirring
of the aqueous solution containing Cefditoren pivoxil at a
temperature of 10 °C or below, to bring about co-precipitation
of Cefditoren pivoxil and the first, water-soluble high-
molecular additive simultaneously from the aqueous solution;
a step of collecting by filtration or centrifugation the so
deposited precipitate from the resulting neutralization
reaction mixture; a step of washing the collected precipitate
with such an aqueous solution which is containing a second,
water-soluble high-molecular additive made of a substance
different from the above-mentioned first, water-soluble
high-molecular additive contained in said acidic aqueous
solution containing Cefditoren pivoxil, and which aqueous
solution is containing said second high molecular additive
dissolved therein at a concentration of 0.5 % ~ 10% (weight/
weight basis), while at least a portion of said second water-
soluble high-molecular additive used here in the washing
aqueous solution is allowed during the washing operation to
transfer from the washing aqueous solution of the second water-
soluble high-molecular additive into the surfaces of the
particles of the precipitate; and a step of then drying the
washed precipitate, to afford the yellow-colored powdery
composition consisting essentially of such particles which
each contains Cefditoren pivoxil, and of which the central
portion or core portion of each particle is formed only from
a homogeneous mixture of the crystallographically stable,
amorphous and water-soluble substance of Cefditoren pivoxil
with the first water-soluble high-molecular additive present
in a proportion of 0.5 % ~ 5 % based on the weight of said
Cefditoren pivoxil substance, and of which the surface layer
of each particle is formed from a homogeneous mixture of the
crystallographically stable, amorphous and water-soluble
substance of Cefditoren pivoxil with said first water-soluble
high-molecular additive and also with said second water-
soluble high-molecular additive.
The process of the fourth aspect of this invention may
be carried out in the same manner as the process of the third
aspect of this invention.
The process of the fourth aspect of this invention is
preferably effected by such a process comprising a step of
dissolving the orthorhombic crystalline substance of
Cefditoren pivoxil in an acidic aqueous solution which is
containing such a water-soluble high-molecular additive as
chosen from hydroxypropylmethyl cellulose, hydroxypropyl
cellulose, methyl cellulose and polyvinylpyrrolidone as
dissolved at a concentration of 0.05 % ~ 1 % (weight/weight
basis) and which acidic aqueous solution is containing also
hydrochloric acid or phosphoric acid at a concentration of
0.5N ~ 2.0N of the acid, so that the amount of Cefditoren
pivoxil dissolved in the acidic aqueous solution is in a range
of 10 times to 100 times based on the whole weight of said
first water-soluble high-molecular additive contained in said
acidic aqueous solution, and so that there is prepared an
acidic aqueous solution containing Cefditoren pivoxil, the
water-soluble high-molecular additive and the acid dissolved
therein; a step of subsequently neutralizing the so prepared
acidic aqueous solution containing Cefditoren pivoxil, by
adding slowly thereto an aqueous 1N ~ 2N sodium hydroxide
solution or/and an aqueous 1N ~ 2N sodium hydrogen carbonate
solution or by adding slowly thereto an aqueous 1N ~ 2N
ammonium hydroxide solution, with maintaining the acidic
aqueous solution at a temperature of 5 °C or below under
stirring, until the acidic aqueous solution is neutralized
to a pH value of 6.5 ~ 7.0; a step of continuing the stirring
of the neutralization reaction mixture at a temperature of
5 °C or below during the neutralization reaction, to bring about
the co-precipitation of Cefditoren pivoxil and said first
water-soluble high-molecular additive simultaneously from
the aqueous solution; a step of collecting the deposited
precipitate from the resulting neutralization reaction
mixture; a step of washing the collected precipitate with such
an aqueous solution which is containing, as the second
water-soluble high-molecular additive made of a substance
different from the above-mentioned first water-soluble
high-molecular additive, such a water-soluble high-molecular
additive as chosen from hydroxypropylmethyl cellulose,
hydroxypropyl cellulose, methyl cellulose and
polyvinylpyrrolidone, and which aqueous solution is
containing said second high-molecular additive dissolved
therein at a concentration of 0.5 % ~ 10 % (weight/weight
basis), while at least a portion of the second water-soluble
high-molecular additive used here in the washing aqueous
solution is allowed during the washing operation to transfer
from said aqueous solution of the second water-soluble
high-molecular additive into the surfaces of the particles
of the precipitate; and a step of then drying the washed
precipitate, to afford the yellow-colored powdery composition
consisting essentially of such particles of which the central
portion or core portion of each particle is formed only from
a homogeneous mixture of the amorphous substance of Cef ditoren
pivoxil with said first water-soluble high-molecular additive,
and of which the surface layer of each particle is formed from
a homogeneous mixture of the amorphous substance of Cefditoren
pivoxil with said first water-soluble high-molecular additive
and also with said second water-soluble high-molecular
additive.
Brief Description of Drawings
Figure 1 shows a pattern of a powder X-ray diffraction
chart obtained by measuring in a powder X-ray diffractometer
the powdery composition which consists essentially of
particles as formed from a homogeneous mixture of the amorphous
substance of Cefditoren pivoxil with hydroxypropylmethyl
cellulose, and which was produced in Example 6 of this
invention given hereinafter.
Figure 2a shows an infrared absorption spectrum (as
measured by the pelleted KBr method) of the Cefditoren pivoxil
component contained in the particles which are essentially
formed from the homogeneous mixture of the amorphous substance
of Cefditoren pivoxil with hydroxypropylmethyl cellulose, and
which were produced in Example 6 of this invention given
hereinafter.
Figure 2b shows an infrared absorption spectrum (as
measured by the pelleted KBr method) of the crystalline
substance of Cefditoren pivoxil (which is the orthorhombic
crystalline substance as obtained in Example 1 of the PCT
International Open-Laying Publication No. W098/12200). The
arrows given in these charts of the infrared absorption spectra
indicate the absorption peaks at the wave number of 1750 cm-1.
Best Mode for Carrying Out the Invention
Now, this invention is concretely illustrated with
reference to typical Examples thereof, but is not limited to
these Examples. The crystalline substance of Cefditoren
pivoxil used in Example 1 ~ 14 given hereinafter is the
orthorhombic crystalline substance of Cefditoren pivoxil (mp.
215 °C, a purity of about 97 %) obtained in Example 1 of the
PCT International Open Laying Publication No. W098/ 12200.
The following Examples 1 ~ 3 illustrate the
preparation of the yellow-colored powdery composition
according to the first aspect of this invention, and Examples
4 ~ 14 illustrate the preparation of the yellow-colored
powdery composition according to the second aspect of this
invention.
Example 1
The crystalline substance (20 g) of 7-[(Z)-2-(2-
aminothiazol-4-yl)-2-methoxyiminoacetamido]-3- [ ( Z ) -2- ( 4-
methylthiazol-5-yl)ethenyl]-3-cephem-4-carboxylic acid
pivaloyloxymethyl ester, namely Cefditoren pivoxil, was
dissolved in an acidic aqueous solution (140 ml) containing
hydroxypropyl cellulose (200 mg) as dissolved therein and
hydrochloric acid at a concentration of 1N of HC1, with taking
a time of 11 minutes for the dissolution of Cefditoren pivoxil
therein. During this dissolution operation, the aqueous
solution was maintained at a temperature of 5 °C or lower. Thus,
there was prepared an acidic aqueous solution (pH 0.6 ) in which
Cefditoren pivoxil had been completely dissolved. This
acidic aqueous solution containing Cefditoren pivoxil was then
neutralized (to a pH of 7.0) by a dropwise slow addition of
a 1N aqueous ammonia (about 138 ml) thereto over a time period
of 60 minutes at a temperature of 5 °C or lower. There occurred
the deposition of precipitate. The resulting neutralization
reaction mixture containing the precipitate as deposited was
then stirred overnight at a temperature of 5 °C or lower.
The deposited precipitate was collected by filtration
of said reaction mixture, and was then washed well with an
aqueous solution of 0.5 % (by weight) of hydroxypropyl
cellulose (60 ml) . The precipitate so washed was dried under
a reduced pressure. Thus, there was afforded 19.6 g of a
yellow-colored powder (the composition of this invention)
consisting essentially of numerous fine particles which each
were formed of a homogeneous mixture of the amorphous substance
of Cefditoren pivoxil with hydroxypropyl cellulose. When
observation was made, under an electron microscope
(magnification: x 10000), of the surface of the fine particles
present in the resulting yellow-colored powder, it was shown
that the surface of these fine particles had a simple and
uniform phase or texture.
The content of hydroxypropyl cellulose contained in
the fine particles present in said resulting yellow-colored
powder was calculated, from an analysis by means of a gas
chromatography, to be 1 % (by weight) on the basis of the
Cefditoren pivoxil component. Further, by analyzing said
fine particles in the above-mentioned powder X-ray diffraction
apparatus, it was found that no peak was appearing in the angle
of diffraction in the pattern of the resulting X-ray
diffraction chart, and therefore that the Cefditoren pivoxil
component present in these fine particles was in the form of
the amorphous substance.
Example 2
The crystalline substance of Cefditoren pivoxil (5 g)
was dissolved in an acidic aqueous solution (35 ml) containing
hydroxypropylmethyl cellulose (50 mg) as dissolved therein
and 1N HC1, at a temperature of 5 °C or lower and with taking
a time of 10 minutes for the dissolution of Cefditoren pivoxil.
Thus, there was prepared an acidic aqueous solution (pH 1.32)
in which Cefditoren pivoxil had been completely dissolved.
The resulting aqueous solution containing Cefditoren pivoxil
was then neutralized (up to a pH of 6.9) by a dropwise slow
addition of a 1N aqueous ammonia (about 33 ml) thereto over
the time period of 30 minutes at a temperature of 5 °C or lower.
There occurred the deposition of precipitate. The resulting
neutralization reaction mixture was then stirred overnight
at a temperature of 5 °C or lower. The deposited precipitate
was collected by filtration, and was then washed well with
an aqueous solution (15 ml) of 0.5 % (by weight) of hydroxy-
propylmethyl cellulose. The precipitate so washed was dried
under a reduced pressure. Thus, there was afforded 4.9 g of
a yellow-colored powder (the composition of this invention)
consisting essentially of numerous fine particles which each
were formed of a homogeneous mixture of the amorphous substance
of Cefditoren pivoxil with hydroxy-propylmethyl cellulose.
The content of hydroxypropylmethyl cellulose contained
in the fine particles present in the resulting yellow-colored
powder was calculated to be 1 % (by weight) on the basis of
the Cefditoren pivoxil component. Further, by analyzing said
fine particles in the above-mentioned powder X-ray diffraction
apparatus, it was found that the Cefditoren pivoxil component
present in these fine particles was in the form of the amorphous
substance.
Example 3
The crystalline substance of Cefditoren pivoxil (5 g)
was dissolved in an acidic aqueous solution (35 ml) containing
polyvinylpyrrolidone (50 mg) as dissolved therein and HC1 at
a concentration of 1N, at a temperature of 5 °C or lower and
with taking a time of 10 minutes for the dissolution of
Cefditoren pivoxil. Thus, there was prepared an acidic
aqueous solution (pH 0.4) in which Cefditoren pivoxil was
completely dissolved. This aqueous solution was then
neutralized by a dropwise slow addition of a 1N aqueous ammonia
(about 34 ml) thereto over 30 minutes at a temperature of 5 °C
or lower. During the neutralization reaction, precipitate
deposited. The resulting neutralization reaction mixture
(pH: 6.8) containing the precipitate as formed was stirred
at a temperature of 5 °C or lower overnight. The deposited
precipitate was collected by filtration, and was then washed
well with an aqueous solution (15 ml) of 0.5 % (by weight)
of polyvinylpyrrolidone. The precipitate so washed was dried
under a reduced pressure. Thus, there was obtained 4.9 g of
a yellow-colored powder consisting essentially of numerous
fine particles which each were formed of a homogeneous mixture
of the amorphous substance of Cefditoren pivoxil with
polyvinylpyrrolidone.
The content of polyvinylpyrrolidone contained in the
fine particles present in the resulting yellow-colored powder
was calculated to be 1 % (by weight) on the basis of the
Cefditoren pivoxil component. By analyzing the said fine
particles in the above-mentioned powder X-ray diffraction
analyzer, it was found that the Cefditoren pivoxil component
existing in these fine particles was in the form of the
amorphous substance.
Example 4
The crystalline substance of Cefditoren pivoxil (10
g) was dissolved in an acidic aqueous solution (100 ml)
containing about 1 g of hydroxypropylmethyl cellulose as
dissolved therein (at a concentration of 1 %) and HC1 at a
concentration of 1N, at a temperature of 10 °C or lower. Thus,
there was prepared an acidic aqueous solution in which
Cefditoren pivoxil was completely dissolved. This acidic
aqueous solution obtained was then neutralized by a dropwise
slow addition of a 1N aqueous sodium hydroxide solution (100
ml) thereto, while the temperature was maintained at 5 °C or
lower. During the neutralization reaction, precipitate
slowly deposited from the aqueous solution. The resulting
neutralization reaction mixture containing the precipitate
was stirred overnight at a temperature of 5 °C or lower.
Then, the neutralization reaction mixture was
filtered, and the precipitate thus collected was placed in
a filtration apparatus which was operated under a reduced
pressure. To the filtration apparatus, an aqueous solution
of 1 % of hydroxypropyl cellulose was added, followed by
washing further the precipitate under pushing pressure. The
precipitate so washed was dried under a reduced pressure, and
there was thus obtained 9.6 g of a yellow-colored powder
consisting essentially of numerous fine particles which each
were formed from a mixture comprising Cefditoren pivoxil and
hydroxypropylmethyl cellulose.
The fine particles present in the resulting yellow-
colored powder were examined by a powder X-ray diffraction
analyzer (Geigerflex 2 027, made by Rigaku Denki K.K.), to
obtain a chart of the powder X-ray diffraction of said fine
particles. The result of an analysis of the pattern of the
resulting X-ray diffraction chart indicated that no peak was
seen in the angle of diffraction in the chart, and that the
Cefditoren pivoxil component present in the fine particles
was in the form of the amorphous substance.
The total content of hydroxypropylmethyl cellulose
plus hydroxypropyl cellulose contained in the fine particles
present in the resulting yellow-colored powder was calculated
to be 2 % (by weight) on the basis of the Cefditoren pivoxil
component.
Further, the aqueous solution of hydroxypropyl
cellulose which had been used for the washing operation of
the precipitate as collected from the neutralization reaction
mixture mentioned in the above was then wholly recovered after
the washing operation. A measurement was then made of the
total residual amount of the hydroxypropyl cellulose remaining
in the aqueous solution of hydroxypropyl cellulose which had
been used in the washing operation and then recovered as above.
The total residual amount so measured of the hydroxypropyl
cellulose present in the so recovered aqueous solution after
the washing step was observed to be significantly less than
the initial, total amount of hydroxylpropyl cellulose which
was initially contained in the aqueous solution of
hydroxypropyl cellulose as just charged in the washing step.
Based on this observed fact, it was deduced that, during the
washing operation of the precipitate, an amount of the
hydroxypropyl cellulose component present as the solute in
the washing aqueous solution had transferred into the
precipitate, at least into the surface of the precipitate,
from the washing aqueous solution of hydroxypropyl cellulose
just employed in said washing step.
Furthermore, when an examination was conducted, under
an electron microscope (magnification x 10000), in respect
of several ones of the fine particles as picked up from the
resulting yellow-colored powder as above, it was shown that
the surface of these fine particles had a simple and uniform
texture or tissue, and further that in the surface of the fine
particles, there was substantially not observed any presence
of independently separate grains of Cefditoren pivoxil or any
presence of independently separate grains of hydroxy-
propylmethyl cellulose or of hydroxypropyl cellulose.
Example 5
The crystalline substance of Cefditoren pivoxil (50
g) was dissolved in an acidic aqueous solution (350 ml)
containing hydroxypropylmethyl cellulose (500 mg) as
dissolved therein and HCl at a concentration of 1N, at a
temperature of 5 °C, and with taking the time over a period
of 45 minutes for the dissolution of Cefditoren pivoxil. The
resulting aqueous solution was filtered through a millipore
(1 µm) membrane filter to remove the insoluble solid matters
from the solution. Thus, there was prepared an acidic aqueous
solution containing Cefditoren pivoxil and hydroxylpropyl-
methyl cellulose completely dissolved therein, as well as
hydrochloric acid.
The resulting acidic aqueous solution here obtained
was then neutralized to a pH of 3 .3 by a dropwise slow addition
of a 1N aqueous sodium hydroxide solution (315 ml), and then
to a pH of 7.0 by a slow addition of a 1N aqueous sodium hydrogen
carbonate solution (43.5 ml), while the temperature of the
resulting reaction solution was maintained at 5 °C or below.
The total period of time taken for the dropwise addition of
the aqueous solutions of the inorganic bases was 1.5 hours
to the completion.
During the neutralization reaction, precipitate
slowly deposited. The resulting neutralization reaction
solution containing the precipitate as formed was then stirred
overnight at a temperature of 5 °C or lower, and then the
reaction solution was again adjusted to its pH of 7.0 by a
dropwise addition of an aqueous 1N sodium hydrogen carbonate
solution.
The neutralization reaction mixture here obtained as
above was filtered to recover the precipitate therefrom. The
resulting precipitate was washed well with an aqueous solution
of 0.5 % (by weight) of hydroxypropyl cellulose (150 ml). The
precipitate so washed was then dried under a reduced pressure.
There was thus obtained 48.5 g of a yellow-colored powder (the
composition of this invention) consisting essentially of
numerous fine particles which each were substantially formed
from a homogeneous mixture comprising the amorphous Cefditoren
pivoxil substance and hydroxypropylmethyl cellulose.
The total content of hydroxypropylmethyl cellulose
plus hydroxypropyl cellulose contained in the fine particles
present in the resulting yellow-colored powder was calculated
to be 1.1 % (by weight) on the basis of the Cefditoren pivoxil
component.
The fine particles present in the resulting yellow-
colored powder were placed in a powder X-ray diffraction
analyzer for an examination thereof. The result of analysis
of the pattern of the X-ray diffraction chart so obtained
indicated that no peak was seen in the angle of diffraction
in the chart, and therefore that the Cefditoren pivoxil
component contained in the fine particles was present in the
form of the amorphous substance. Further, when an examination
was made under an electron microscope in respect of several
ones of the fine particles so obtained, it was shown that the
surface of the particles had a simple uniform texture, and
that there was substantially not observed the presence of any
independently separate grains in the surface of the fine
particles.
It is deemed that the fine particles present in the
yellow-colored powder as obtained in this Example have such
structure that the central portion or core portion of these
fine particles is formed of a homogeneous mixture comprising
the amorphous substance of Cefditoren pivoxil and
hydroxypropylmethyl cellulose, while the surface layer of
said fine particles is formed of a homogeneous mixture
comprising the amorphous substance of Cefditoren pivoxil,
hydroxypropylmethyl cellulose and hydroxypropyl cellulose.
Comparative Example 1
The procedure of Example 5 was repeated in the
substantially same manner as in Example 5, except that the
use of both the hydroxypropylmethyl cellulose and hydroxy-
propyl cellulose was completely omitted. In other words, the
crystalline substance of Cef ditoren pivoxil (5 g) was dissolved
in water (50 ml) containing 1N HCl, with taking a period of
23 minutes for the dissolution of Cefditoren pivoxil, while
the temperature of the solution was maintained at 5 °C or lower.
After the completion of the dissolution of Cefditoren pivoxil
in the acidic water, an aqueous 1N sodium hydroxide solution
(40 ml) was slowly added dropwise to the resulting acidic
aqueous solution of Cefditoren pivoxil to neutralize the
latter solution to a pH of 2.1. Then, an aqueous 1N sodium
hydrogen carbonate solution (10 ml) was added dropwise to the
aqueous solution of Cefditoren pivoxil to neutralize the
solution further. During the neutralization step, the
reaction solution was maintained at a temperature of 5 °C or
lower. Total time taken for the completion of the addition
of these aqueous solutions of the inorganic bases was 27
minutes.
The resulting neutralization reaction mixture
containing the precipitate as formed (pH 6.2) was stirred for
1.5 hours at a temperature of 5 °C or lower, and then was
neutralized further to a pH of 7.0 by a dropwise addition of
an aqueous 1N sodium hydrogen carbonate solution.
During the latter neutralization reaction step,
precipitate of Cefditoren pivoxil deposited from the aqueous
solution. The neutralization reaction mixture obtained here
was stirred at a temperature of 5 °C or lower overnight.
The here obtained neutralization reaction mixture
containing the precipitate was filtered to recover the
deposited precipitate. The precipitate so collected was
washed well with water (25 ml) as cooled to 5 °C. The
precipitate so washed was dried to afford a fine powder (4.4
g) which was formed of a crystalline substance of Cefditoren
pivoxil. The fine particles present in said fine powder was
examined by the powder X-ray diffraction analyzer, to indicate
that a peak was appearing in the angle of diffraction in the
pattern of the resulting X-ray diffraction chart. It was thus
deduced that the Cefditoren pivoxil component contained in
the fine powder obtained here was present in the form of a
crystalline substance.
Example 6
The crystalline substance of Cefditoren pivoxil (50
g) was dissolved over 45 minutes in an acidic aqueous solution
(350 ml) containing hydroxypropylmethyl cellulose (500 mg)
as dissolved therein and HC1 at a concentration of 1N at a
temperature of 5 °C or lower. The resulting aqueous solution
containing Cefditoren pivoxil was filtered through amillipore
(1 µm) membrane filter to remove the insoluble solid matters
therefrom. Thus, there was prepared an acidic aqueous
solution in which Cefditoren pivoxil, hydroxypropylmethyl
cellulose and hydrochloric acid were completely dissolved.
The acidic aqueous solution obtained here was
neutralized to a pH of 7.0 by a dropwise slow addition of a
1N aqueous ammonia, namely an aqueous solution of 1N ammonium
hydroxide (331 ml), while the acidic aqueous solution was
maintained at a temperature of 5 °C or lower. The total time
taken for the completion of the dropwise addition of the
aqueous ammonia was 1.5 hours. During this neutralization
reaction, precipitate slowly deposited. The resulting
neutralization reaction mixture containing the precipitate
as formed was then stirred overnight at a temperature of 5 °C
or lower. Then, the pH of the reaction mixture was again
adjusted to a pH of 7.0 by a dropwise addition of a 1N aqueous
ammonia.
The neutralization reaction mixture here obtained as
above was filtered to recover the precipitate therefrom. The
resulting precipitate was washed well with an aqueous solution
of 0.5 % (by weight) of hydroxypropyl cellulose (150 ml) . The
precipitate so washed was then dried under a reduced pressure.
There was thus obtained 48.8 g of a yellow-colored powder (the
composition of this invention) consisting essentially of
numerous fine particles which each were formed substantially
from a homogeneous mixture comprising the amorphous substance
of Cefditoren pivoxil and hydroxypropylmethyl cellulose.
The fine particles present in the resulting yellow-
colored powder was analyzed by a high performance liquid
chromatography, to detect that the fine particles had a content
of 96 % (by weight) of the Cefditoren pivoxil component based
on the weight of the fine particles. Further, the total
content of hydroxypropylmethyl cellulose plus hydroxypropyl
cellulose contained in the fine particles was calculated to
be 1.3 % (by weight) based on the weight of the Cefditoren
pivoxil component.
The fine particles present in the resulting yellow-
colored powder were placed in and examined by the powder X-ray
diffraction analyzer (Geigerflex 2027, made by Rigaku Denki
K.K. ) , to give a chart of the powder X-ray diffraction of said
fine particles. The result of analysis of the pattern of the
X-ray diffraction chart revealed that no peak was seen in the
angle of diffraction in the chart, and therefore that the
Cefditoren pivoxil component contained in the fine particles
was present in the form of the amorphous substance. Further,
the examination was made under an electron microscope in
respect of several ones of the fine particles, it was shown
that the surface of the fine particles had a simple and uniform
texture and further that any independently separate grains
are substantially absent in the surface of the fine particles.
It is deemed that the fine particles present in the
yellow-colored powder as obtained in this Example have such
structure that the central portion or core portion of these
fine particles is formed of a homogeneous mixture comprising
the amorphous substance of Cefditoren pivoxil and hydroxy-
propylmethyl cellulose, while the surface layer of the fine
particles is formed of a homogeneous mixture comprising the
amorphous substance of Cefditoren pivoxil and hydroxypropyl-
methyl cellulose and hydroxypropyl cellulose.
A diffraction chart of the powder X-ray diffraction
which was given by measuring the fine particles of the
yellow-colored powder as produced in this Example in the powder
X-ray diffraction analyzer (Geigerflex 2027, made by Rigaku
Denki K. K.), is shown in Figure 1 of the attached drawings.
An infrared absorption spectrum (measured by the
pelleted KBr method) of the amorphous substance of Cefditoren
pivoxil present in the fine particles just mentioned above
was also measured by placing said fine particles in an infrared
spectrometer.
The chart of the infrared absorption spectrum thus
obtained is shown in Figure 2a of the attached drawings. An
infrared absorption spectrum was similarly measured for the
crystalline substance of Cefditoren pivoxil used in this
Example as the starting material, and the measured chart
thereof is also shown in Figure 2b of the attached drawings.
Comparative Example 2
The procedure of Example 6 was repeated in substantially
the same manner as in Example 6, except that the use of both
of hydroxypropylmethyl cellulose and hydroxypropyl cellulose
was omitted.
Namely, Cefditoren pivoxil in the form of a crystalline
substance(20 g) was dissolved over 3 hours in a volume of water
(190 ml) containing HC1 at a concentration of 1N, at a
temperature of 5 °C or lower. After the completion of the
dissolution of Cefditoren pivoxil in the acidified water, the
resulting aqueous solution was filtered through a millipore
(1.0 µm) membrane filter. The resulting acidic aqueous
solution containing Cefditoren pivoxil was then neutralized
to a pH of 6.03 by a dropwise slow addition of a 1N aqueous
ammonia (192 ml), while the acidic solution was maintained
at a temperature of 5 °C or lower. The resulting
neutralization reaction mixture containing the precipitate
as formed (pH 6.03) was stirred overnight at a temperature
of 5 °C or lower, and then 1N aqueous ammonia was again added
dropwise to adjust the pH of the reaction mixture to pH 5.8.
During this step of the neutralization reaction, precipitate
of Cefditoren pivoxil deposited from the aqueous solution.
The neutralization reaction mixture obtained here was stirred
at a temperature of 5 °C or lower overnight.
The resultant neutralization reaction mixture
containing the precipitate was filtered to recover the
deposited precipitate. The collected precipitate was washed
well with cold water at 5 °C (60ml). The precipitate so washed
was dried to afford a fine powder (19.4 g) which was formed
of a crystalline substance of Cefditoren pivoxil. The
resulting fine powder obtained here was examined by the powder
X-ray diffraction analyzer, to indicate that a peak was
appearing in the angle of diffraction in the pattern of the
X-ray diffraction chart so obtained. It is thus confirmed that
the Cefditoren pivoxil component contained in the resulting
fine particles was present in the crystalline substance form.
Example 7
The crystalline substance of Cefditoren pivoxil (5 g)
was dissolved over 16 minutes in an acidic aqueous solution
(35 ml) containing hydroxypropylmethyl cellulose (50 mg) as
dissolved therein and HC1 at a concentration of 1N, at a
temperature of 5 °C or lower. Thus, there was prepared an
acidic aqueous solution (pH 0.8) in which Cefditoren pivoxil,
hydroxypropylmethyl cellulose and hydrochloric acid were
completely dissolved.
The resulting acidic aqueous solution was neutralized
to a pH of 6.7 by a dropwise slow addition of a 1N aqueous
ammonia (about 34 ml), while the acidic aqueous solution was
maintained at a temperature of 5 °C or lower. The time taken
for the completion of the dropwise addition of the aqueous
ammonia was 33 minutes. During the neutralization reaction,
precipitate slowly deposited. The resulting neutralization
reaction mixture containing the precipitate as formed was
stirred overnight at a temperature of 5 °C or lower.
The neutralization reaction mixture obtained here was
filtered to collect the precipitate. The resulting precipitate
was washed well with an aqueous solution of a 0.5 % (by weight)
of hydroxypropyl cellulose (75 ml). The precipitate so washed
was then dried under a reduced pressure. There was thus
obtained 4.8 g of a yellow-colored powder (the composition
of this invention) consisting essentially of numerous fine
particles which each were formed substantially from a
homogeneous mixture comprising the amorphous substance of
Cefditoren pivoxil and hydroxypropylmethyl cellulose.
The total content of hydroxypropylmethyl cellulose and
hydroxypropyl cellulose contained in the fine particles
present in the resulting yellow-colored powder was calculated
to be 1.1 % (by weight) based on the weight of the Cefditoren
pivoxil component.
The fine particles obtained here were placed in and
examined by the powder X-ray diffraction analyzer. The result
of analysis of the pattern of the resulting X-ray diffraction
chart indicated that no peak was seen in the angle of
diffraction, and therefore that the Cefditoren pivoxil
component contained in the fine particles was present in the
form of the amorphous substance. Further, an examination was
made under an electron microscope in respect of several ones
of the fine particles to show that the surface of the fine
particles had a simple and uniform phase or texture.
It is deemed that the fine particles present in the
yellow-colored powder as obtained in this Example have such
structure that the central portion or core portion of these
fine particles is formed of a homogeneous mixture comprising
the amorphous substance of Cefditoren pivoxil and hydroxy-
propylmethyl cellulose, while the surface layer of the fine
particles is formed of a homogeneous mixture comprising the
amorphous substance of Cefditoren pivoxil, hydroxypropylmethyl
cellulose and hydroxypropyl cellulose.
Example 8
The crystalline substance of Cefditoren pivoxil (5g)
was dissolved over 10 minutes in an acidic aqueous solution
(35 ml) containing hydroxypropylmethyl cellulose (100 mg) as
dissolved therein and HCl at a concentration of 1N, at a
temperature of 5 °C or lower. Thus, there was prepared an
acidic aqueous solution (pH 0.7) in which Cefditoren pivoxil,
hydroxypropylmethyl cellulose and hydrochloric acid were
completely dissolved.
The acidic aqueous solution obtained here was
neutralized to a pH of 7.0 by a dropwise slow addition of a
1N aqueous ammonia (about 34 ml), while the acidic aqueous
solution being maintained at a temperature of 5 °C or lower.
The time taken for the completion of the dropwise addition
of the aqueous ammonia was 3 0 minutes. During the
neutralization reaction, precipitate slowly deposited. The
so obtained neutralization reaction solution containing the
precipitate was stirred at a temperature of 5 °C or lower
overnight.
The neutralization reaction mixture obtained as above
was filtered to collect the precipitate. The resulting
precipitate was washed well with an aqueous solution of 0.5 %
(by weight) of hydroxypropyl cellulose (15 ml). The
precipitate so washed was then dried under a reduced pressure.
There was thus obtained 5 g of a yellow-colored powder (the
composition of this invention) consisting essentially of
numerous fine particles which each were formed substantially
from a homogeneous mixture comprising the amorphous substance
of Cefditoren pivoxil and hydroxypropylmethyl cellulose.
The total content of hydroxypropylmethyl cellulose plus
hydroxypropyl cellulose contained in the fine particles
present in the resulting yellow-colored powder was calculated
to be 2.0 % (by weight) based on the weight of the Cefditoren
pivoxil component.
The fine particles obtained were placed in and
examined by the powder X-ray diffraction analyzer. The result
of analysis of the pattern of the resulting X-ray diffraction
chart indicated that no peak was appearing in the angle of
diffraction, and therefore that the Cefditoren pivoxil
component contained in the fine particles was present in the
form of the amorphous substance.
It is deemed that the fine particles present in the
yellow-colored powder as obtained in this Example have such
structure that the central portion or core portion of these
fine particles is formed of a homogeneous mixture comprising
the amorphous substance of Cefditoren pivoxil and hydroxy-
propylmethyl cellulose, but the surface layer of the fine
particles is formed of a homogeneous mixture comprising the
amorphous substance of Cefditoren pivoxil, hydroxypropyl-
methyl cellulose and hydroxypropyl cellulose.
Example 9
The crystalline substance of Cefditoren pivoxil (5 g)
was dissolved over 10 minutes in an acidic aqueous solution
(35 ml) containing hydroxypropylmethyl cellulose (40 mg) as
dissolved therein and HC1 at a concentration of 1N at a
temperature of 5 °C or lower. Thus, there was prepared an
acidic aqueous solution (pH 0.4) in which Cefditoren pivoxil,
hydroxypropylmethyl cellulose and hydrochloric acid were
completely dissolved.
The resulting acidic aqueous solution obtained here
was neutralized to a pH of 6.9 by a dropwise slow addition
of a 1N aqueous ammonia (about 34 ml), while the acidic aqueous
solution being maintained at a temperature of 5 °C or lower.
The time taken for the completion of the dropwise addition
of the aqueous ammonia was 3 0 minutes. During the
neutralization reaction, precipitate slowly deposited. The
resulting neutralization reaction solution containing the
precipitate as formed was stirred overnight at a temperature
of 5 °C or lower.
The neutralization reaction mixture obtained as above
was then filtered to collect the precipitate. The resulting
precipitate was washed well with an aqueous solution of 0.5 %
(by weight) of hydroxypropyl cellulose (15 ml). The
precipitate so washed was then dried under a reduced pressure.
There was thus obtained 5 g of a yellow-colored powder (the
composition of this invention) consisting essentially of
numerous fine particles which each were formed substantially
from a homogeneous mixture comprising the amorphous substance
of Cefditoren pivoxil and hydroxypropylmethyl cellulose.
The total content of hydroxypropylmethyl cellulose
and hydroxypropyl cellulose contained in the fine particles
present in the resulting yellow-colored powder was calculated
to be 1.1 % (by weight) based on the weight of the Cefditoren
pivoxil component.
The fine particles thus obtained were placed in and
examined by the powder X-ray diffraction analyzer. The result
of analysis of the pattern of the resulting X-ray diffraction
chart indicated that no peak was appearing in the angle of
diffraction, and therefore that the Cefditoren pivoxil
component contained in the fine particles was present in the
form of the amorphous substance.
It is deemed that the fine particles present in the
yellow-colored powder as obtained in this Example have such
structure that the central portion or core portion of these
fine particles is formed of a homogeneous mixture comprising
the amorphous substance of Cefditoren pivoxil and
hydroxypropylmethyl cellulose, but the surface layer of the
fine particles is formed of a homogeneous mixture comprising
the amorphous substance of Cefditoren pivoxil, hydroxy-
propylmethyl cellulose and hydroxypropyl cellulose.
Example 10
The crystalline substance of Cefditoren pivoxil (5 g)
was dissolved over 10 minutes in an acidic aqueous solution
(35 ml) containing hydroxypropyl cellulose (50 mg) as
dissolved therein and HCl at a concentration of 1N at a
temperature of 5 °C or lower. Thus, there was prepared an
acidic aqueous solution (pH 0.7) in which Cefditoren pivoxil,
hydroxypropyl cellulose and hydrochloric acid were completely
dissolved.
The resulting acidic aqueous solution obtained here
was neutralized to a pH of 6.7 by a dropwise slow addition
of a 1N aqueous ammonia (about 34 ml), while the acidic aqueous
solution being maintained at a temperature of 5 °C or lower.
The time taken for the completion of the dropwise addition
of the aqueous ammonia was 36 minutes. During the
neutralization reaction, precipitate slowly deposited. The
resulting neutralization reaction solution containing the
precipitate as formed was stirred overnight at a temperature
of 5 °C or lower.
The neutralization reaction mixture obtained as above
was filtered to collect the precipitate. The resulting
precipitate was washed well with an aqueous solution of 0.5 %
(by weight) of hydroxypropylmethyl cellulose (15 ml). The
precipitate so washed was then dried under a reduced pressure.
There was thus obtained 5 g of a yellow-colored powder (the
composition of this invention) consisting essentially of
numerous fine particles which each were formed substantially
from a homogeneous mixture comprising the amorphous substance
of Cefditoren pivoxil and hydroxypropyl cellulose.
The total content of hydroxypropyl cellulose and
hydroxypropylmethyl cellulose contained in the fine particles
present in the resulting yellow-colored powder was calculated
to be 1 % (by weight) based on the weight of the Cefditoren
pivoxil component.
The fine particles thus obtained were placed in and
examined by the powder X-ray diffraction analyzer. The result
of analysis of the pattern of the resulting X-ray diffraction
chart indicated that no peak was appearing in the angle of
diffraction in said chart, and therefore that the Cefditoren
pivoxil component contained in the fine particles was present
in the form of the amorphous substance.
It is deemed that the fine particles present in the
yellow-colored powder as obtained in this Example have such
structure that the central portion or core portion of these
fine particles is formed of a homogeneous mixture comprising
the amorphous substance of Cefditoren pivoxil and hydroxy-
propyl cellulose, but the surface layer of the fine particles
is formed of a homogeneous mixture comprising the amorphous
substance of Cefditoren pivoxil, hydroxypropyl cellulose and
hydroxypropylmethyl cellulose.
Example 11
The crystalline substance of Cefditoren pivoxil (5 g)
was dissolved over 10 minutes in an acidic aqueous solution
(35 ml) containing hydroxypropyl cellulose (50 mg) as
dissolved therein and HC1 at a concentration of 1N at a
temperature of 5 °C or lower. Thus, there was prepared an
acidic aqueous solution (pH 0.3) in which Cefditoren pivoxil,
hydroxypropyl cellulose and hydrochloric acid were completely
dissolved.
The resulting acidic aqueous solution obtained here
was neutralized to a pH of 6.9 by a dropwise slow addition
of a 1N aqueous ammonia (about 34.5 ml), while the acidic
aqueous solution being maintained at a temperature of 5 °C or
lower. The time taken for the completion of the dropwise
addition of the aqueous ammonia was 43 minutes. During the
neutralization reaction, precipitate slowly deposited. The
resulting neutralization reaction solution containing the
precipitate as formed was stirred at a temperature of 5 °C or
lower overnight.
The neutralization reaction mixture obtained as above
was filtered to collect the precipitate. The resulting
precipitate was washed well with an aqueous solution of 0.5 %
(by weight) of methyl cellulose (15 ml). The precipitate so
washed was then dried under a reduced pressure. There was thus
obtained 4.9 g of a yellow-colored powder (the composition
of this invention) consisting essentially of numerous fine
particles which each were formed substantially from a
homogeneous mixture comprising the amorphous substance of
Cefditoren pivoxil and hydroxypropyl cellulose.
The total content of hydroxypropyl cellulose and
methyl cellulose contained in the fine particles present in
the resulting yellow-colored powder was calculated to be 1 %
(by weight) based on the weight of the Cefditoren pivoxil
component.
The fine particles thus obtained were placed in and
examined by the powder X-ray diffraction analyzer. The result
of analysis of the pattern of the resulting X-ray diffraction
chart indicated that no peak was appearing in the angle of
diffraction in said chart, and therefore that the Cefditoren
pivoxil component contained in the fine particles was present
in the form of the amorphous substance.
It is deemed that the fine particles contained in the
yellow-colored powder as obtained in this Example have such
structure that the central portion or core portion of these
fine particles is formed of a homogeneous mixture comprising
the amorphous substance of Cefditoren pivoxil and hydroxy-
propyl cellulose, but the surface layer of the fine particles
is formed of a homogeneous mixture comprising the amorphous
substance of Cefditoren pivoxil, hydroxypropyl cellulose and
methyl cellulose.
Example 12
The crystalline substance (5 g) was dissolved over
10 minutes in an acidic aqueous solution (35 ml) containing
hydroxypropylmethyl cellulose (50 mg) as dissolved therein
and 1N-HC1 at a temperature of 5 °C or lower. Thus, there was
prepared an acidic aqueous solution (pH 1.1) in which
Cefditoren pivoxil, hydroxypropylmethyl cellulose and
hydrochloric acid were completely dissolved.
The resulting acidic aqueous solution obtained here
was neutralized to a pH of 7.0 by a dropwise slow addition
of a 1N aqueous ammonia (about 34 ml), while the acidic aqueous
solution being maintained at a temperature of 5 °C or lower.
The time taken for the completion of the dropwise addition
of the aqueous ammonia was 50 minutes. During the neut-
ralization reaction, precipitate slowly deposited. The
resulting neutralization reaction solution containing the
precipitate as formed was stirred at a temperature of 5 °C or
lower overnight.
The neutralization reaction mixture here obtained as
above was filtered to collect the precipitate. The resulting
precipitate was washed well with an aqueous solution of 0.5 %
(by weight) of hydroxypropyl cellulose (15 ml). The
precipitate so washed was then dried under a reduced pressure.
There was thus obtained 4.9 g of a yellow-colored powder (the
composition of this invention) consisting essentially of
numerous fine particles which each were formed substantially
from a homogeneous mixture comprising the amorphous substance
of Cefditoren pivoxil and hydroxypropylmethyl cellulose.
The total content of hydroxypropylmethyl cellulose
and hydroxypropyl cellulose contained in the fine particles
present in the resulting yellow-colored powder was calculated
to be 1.1 % (by weight) based on the weight of the Cefditoren
pivoxil component.
The fine particles thus obtained were placed in and
examined by the powder X-ray diffraction analyzer. The result
of analysis of the pattern of the resulting X-ray diffraction
chart indicated that no peak was appearing in the angle of
diffraction in the chart, and therefore that the Cefditoren
pivoxil component contained in the fine particles was present
in the form of the amorphous substance.
It is deemed that the fine particles contained in the
yellow-colored powder as obtained in this Example have such
structure that the central portion or core portion of these
fine particles is formed of a homogeneous mixture comprising
the amorphous substance of Cefditoren pivoxil and hydroxy-
propylmethyl cellulose, but the surface layer of the fine
particles is formed of a homogeneous mixture comprising the
amorphous substance of Cefditoren pivoxil,
hydroxypropylmethyl cellulose and hydroxypropyl cellulose.
Example 13
The crystalline substance of Cefditoren pivoxil (5 g)
was dissolved over 16 minutes in an acidic aqueous solution
(35 ml) containing methyl cellulose (50 rag) as dissolved
therein and HC1 at a concentration of 1N, at a temperature
of 5 °C or lower. Thus, there were prepared an acidic aqueous
solution (pH 0.4) in which Cefditoren pivoxil, methyl
cellulose and hydrochloric acid were completely dissolved.
The resulting acidic aqueous solution obtained here
was neutralized to a pH of 6.7 by a dropwise slow addition
of a 1N aqueous ammonia (about 34 ml), while the acidic aqueous
solution being maintained at a temperature of 5 °C or lower.
The time taken for the completion of the dropwise addition
of the aqueous ammonia was 40 minutes. During the
neutralization reaction, precipitate slowly deposited. The
resulting neutralization reaction solution containing the
precipitate as formed was stirred at a temperature of 5 °C or
lower overnight.
The neutralization reaction mixture here obtained as
above was filtered to collect the precipitate. The resulting
precipitate was washed well with an aqueous solution of 0.5 %
(by weight) of hydroxypropyl cellulose (15 ml). The
precipitate so washed was then dried under a reduced pressure.
There was thus obtained 4.9 g of a yellow-colored powder (the
composition of this invention) consisting essentially of
numerous fine particles which each were formed substantially
from a homogeneous mixture comprising the amorphous substance
of Cefditoren pivoxil and methyl cellulose.
The total content of methyl cellulose and
hydroxypropyl cellulose contained in the fine particles
present in the resulting yellow-colored powder was calculated
to be 2 % (by weight) based on the weight of the Cefditoren
pivoxil component.
The fine particles thus obtained were placed in and
examined by the powder X-ray diffraction analyzer. The result
of analysis of the pattern of the resulting X-ray diffraction
chart indicated that no peak was appearing in the angle of
diffraction in the chart, and therefore that the Cefditoren
pivoxil component contained in the fine particles was present
in the form of the amorphous substance.
It is deemed that the fine particles present in the
yellow-colored powder as obtained in this Example have such
structure that the central portion or core portion of these
fine particles is formed of a homogeneous mixture comprising
the amorphous substance of Cefditoren pivoxil and methyl
cellulose, but the surface layer of the fine particles is formed
of a homogeneous mixture comprising the amorphous substance
of Cefditoren pivoxil, methyl cellulose and hydroxypropyl
cellulose.
Example 14
The crystalline substance of Cefditoren pivoxil (5 g)
was dissolved over 10 minutes in an acidic aqueous solution
(35 ml) containing methyl cellulose (50 mg) as dissolved
therein and HC1 at a concentration of 1N at a temperature of
5 °C or lower. Thus, there was prepared an acidic aqueous
solution (pH 0.3) in which Cefditoren pivoxil, methyl
cellulose and hydrochloric acid were completely dissolved.
The resulting acidic aqueous solution obtained here
was then neutralized to a pH of 6.7 by a dropwise slow addition
of a 1N aqueous ammonia (about 34.5 ml), while the acidic
aqueous solution being maintained at a temperature of 5 °C or
lower. The time taken for the completion of the dropwise
addition of the aqueous ammonia was 23 minutes. During the
neutralization reaction, precipitate slowly deposited. The
resulting neutralization reaction solution containing the
precipitate as produced was stirred at a temperature of 5 °C
or lower overnight.
The neutralization reaction mixture obtained as above
was filtered to collect the precipitate. The resulting
precipitate was washed well with an aqueous solution of 0.5 %
(by weight) of hydroxypropylmethyl cellulose (15 ml). The
precipitate so washed was then dried under a reduced pressure.
There was thus obtained 4.9 g of a yellow-colored powder (the
composition of this invention) consisting essentially of
numerous fine particles which each were formed substantially
from a homogeneous mixture comprising the amorphous substance
of Cefditoren pivoxil and methyl cellulose.
The total content of methyl cellulose and hydroxy-
propylmethyl cellulose contained in the fine particles present
in the resulting yellow-colored powder was calculated to be
1.1 % (by weight) based on the weight of the Cefditoren pivoxil
component.
The fine particles thus obtained were placed in and
examined by the powder X-ray diffraction analyzer. The result
of analysis of the pattern of the resulting X-ray diffraction
chart indicated that no peak was appearing in the angle of
diffraction in the chart, and therefore that the Cefditoren
pivoxil component contained in the fine particles was present
in the form of the amorphous substance.
It is deemed that the fine particles contained in the
yellow-colored powder as obtained in this Example have such
structure that the central portion or core portion of these
fine particles is formed of a homogeneous mixture comprising
the amorphous substance of Cefditoren pivoxil and methyl
cellulose, but the surface layer of the fine particles is
formed of a homogeneous mixture comprising the amorphous
substance of Cefditoren pivoxil, methyl cellulose and
hydroxypropylmethyl cellulose.
Test Example 1
There was taken as a sample one gram of the
yellow-colored powder (the composition of this invention),
which was obtained in Example 6 above, and which consisted
essentially of the particles as formed substantially from a
homogeneous mixture comprising the amorphous substance of
Cefditoren pivoxil and hydroxypropylmethyl cellulose, and in
which the surface layer of said particles contained
additionally hydroxypropyl cellulose. The sample so taken
was placed in 250 ml of an acidic water (pH 1.2) containing
about 1N HC1 at 3 7 °C and stirred at 3 7 °C for 2 hours. The
resulting aqueous solution was passed through a millipore
(1 µm) membrane filter to remove the insoluble solid therefrom.
The transparent aqueous solution here obtained, which
contained Cefditoren pivoxil and the water-soluble cellulose
derivatives above-mentioned as dissolved therein, was then
measured in respect of the concentration of the Cefditoren
pivoxil. By this measuring test, the amorphous substance of
Cefditoren pivoxil contained in said yellow-colored powder
was found to have a solubility of at least 4 mg/ml in said
acidic water at 37 °C .
On the other hand, a test similar to that given in the
above was carried out to measure the solubility of the
crystalline substance of Cefditoren pivoxil (the orthorhomic
crystalline substance of Cefditoren pivoxil as obtained in
Example 1 of the PCT application International Open-Laying
Publication NO.W098/12200), which was used as the starting
material. This crystalline substance of Cefditoren pivoxil
was found to have a solubility of only about 0.4 mg/ml in the
above-mentioned acidic water at 3 7 °C.
Test Example 2
Five grams of the yellow-colored powdery composition
as obtained in the above Example 6 were placed in a sealed
container and then stored therein at 4 0 °C under an atmosphere
of dry air for 4 months. After the storage, the yellow-colored
powdery composition was taken out from the container, and
measured for its X-ray diffraction in the powder X-ray
diffraction analyzer same as that used in Example 6. An
analysis of the pattern of the resulting X-ray diffraction
chart indicated that no peak was appearing in the angle of
diffraction in the chart. It was thus found that the
Cefditoren pivoxil contained in the fine particles present
in the above-mentioned yellow-colored powder, even after its
storage at 40 °C for 4 months, could remain in the form of the
amorphous substance and therefore has a crystallographical
stability.
Industrial Applicability
The yellow-colored powdery composition consisting
essentially of the particles as formed from a homogeneous
mixture of the amorphous substance of Cefditoren pivoxil with
a water-soluble high-molecular additive, for example, a
water-solubilized cellulose derivative is now provided
according to this invention, and said composition is orally
administrable and is useful as such an orally administrable
antibacterial agent which has a broad antibacterial spectrum.
The Cefditoren pivoxil component contained in this composition
has a high solubility in an HCl-acidified water having a pH
value of about 1.2 and hence the composition of this invention
can exhibit a high therapeutic efficacy when administered
orally.
WE CLAIM:
1. An orally administrable, yellow -colored powdery composition consisting
essentially of solid particles which each are formed of a homogeneous
mixture of a crystallographically stable, amorphous and water-soluble
substance of Cefdrtoren pivoxil with a water-soluble high-molecular
additive, and which particles have a uniform, internal texture within each
particle, characterized in that said yellow-colored powdery composition
consists essentially of the solid particles each formed of the homogeneous
mixture of (i) the crystallographically stable, amorphous and water-soluble
substance of Cefdrtoren pivoxil, namely 7-[(Z)-2-(2-aminothiazol-4-yl)-2-
methoxyiminoacetamido]-3-[(Z)-2-(4-methylthiazol-5-yl)ethenyl]-3-
cephem-4-carboxylic acid pivaloyloxymethyl ester, with (ii) the water-
soluble high-molecular additive which is either such a pharmaceutically
acceptable, water-solubilized derivative of cellulose as chosen from
hydroxypropylmethyl cellulose, hydroxypropylmethyl cellulose phthalate,
hydroxypropyl cellulose, methyl cellulose and a pharmaceutically
acceptable alkali metal salt or alkaline earth metal salt of carboxymethyl
cellulose, or pluran, carrageenan, polyvinylpynolidone or an alginic acid
ester of polypropylene grycol, that the water-soluble high-molecular
additive (ii) contained in the above-mentioned solid particles is present in
said particles in a proportion of 0.5%-5% based on the weight of the
Cefdrtoren pivoxil substance, that said particles fuse at a temperature of
120°C. or higher, but do not show any definite melting point, that the
amorphous substance of Cefditoren pivoxil (i) contained in said particles
does not show any peak of the angle of diffraction in a X-ray powder
diffractometry chart of said particles but exhibits in its infrared absorption
spectrum (as measured by pelleted potassium bromide method) a
substantially broader peak of absorption at a wave number of 1750 cm-1,
at compared with the sharp peak of absorption exhibited by the
orthorhombic crystalline substance of Cefditoren pivoxil at a wave number
of 1750 cm-1 in the infrared absorption spectrum, and that the amorphous
substance of Cefditoren pivoxil (i) contained in said particles can be
dissolved in an acidified water containing hydrochloric acid (pH 1.2) at a
solubility of at least 4 mg/ml of Cefditoren pivoxil at 37°C and has a
crystallographical stability such that said amorphous Cefditoren pivoxil
substance does not crystailize when stored at 40°C for 4 months in a
sealed container under dry conditions.
2. A composition as claimed in claim 1, which consists essentialy of particles
each formed of a homogeneous mixture of the crystallographically stable,
amorphous and water-soluble substance of Cefditoren pivoxil with
hydroxypropylmethyl cellulose, hydroxypropyl cellulose, methylcellulose or
polyvinylpyrrolidone blended as the water-soluble high-molecular additive
which is present in an amount of 1%-3% based on the weight of
Cefditoren pivoxil.
3. An orally administrable yelow-colored powdery composition consisting
essentialy of particles which each substentially comprise mixtures of a
crystallographically stable, amorphous and water-soluble substance of
Cefditoren pivoxil with water-soluble high-molecular additive or additives,
and which particles have a uniform, internal texture within each particle,
wherein the yelow-colored powdery composition consists essentially of
the particles each substantiafly comprising a mixture of (i) the
crystallographically stable, amorphous and water-soluble substance of
Cefditoren pivoxil, namely 7-[(Z-2-(2-aminothiazol-4-yl)-2-
methoxyiminoacetamido]-3-[(Z)-2-(4-methylthiazol-5-yl)ethenyl]-3-
cephem-4-carboxylic acid pivaloyloxymethyl ester, with (ii) a first, water-
soluble high-molecular additive which is either such a pharmaceutically
acceptable, water-solubilized derivative of cellulose as chosen from
hydroxy-propylmethyl cellulose, hydroxypropylmethyl cellulose phthalate,
hydroxypropyl cellulose, methyl cellulose and a pharmaceutically
acceptable alkall metal salt or alkaline earth metal salt of carboxymethyl
cellulose, or pluran, carrageenan, polyvinylpyrrolidone or an alginic acid
eater of polypropylene glycol, that the central portion or core portion of the
respective particles which is lying under the surface layer of said
respective particles is formed only from a homogeneous mixture of (i) the
amorphous substance of Cefditoren pivoxil with (ii) the above-mentioned
first, water-soluble high-molecular additive, but the surface layer of said
particles is formed from a homogeneous mixture of (i) the amorphous
substance of Cefditoren pivoxil with (ii) the first water-soluble high-
molecular additive and also with (iii) such a second, water-soluble high-
molecular additive which is additionally incorporated, which is made of a
substance different from the above-mentioned first water-soluble high-
molecular additive present just in the central portion or core portion of said
particles lying under said surface layer of the particle, and which second,
water-soluble high-molecular additive is selected from
hydroxypropylmethyl cellulose, hydroxypropyt cellulose, methylcellulose
and polyvinylpyrrolidono, that both the first water-soluble high-molecular
additive (I) and the second water-soluble high-molecular additive (iii) are
present in a total proportion of them of 0.5%-5% based on the weight of
the Cefditoren pivoxil substance contained in said particles, that said
particles fuse at a temperature of 120°C or higher, but do not show any
definite melting point, that the amorphous substance of CefdHoren pivoxil
(i) contained in said particles does not show any peak of the angle of
diffraction in a powder X-ray diffractometry chart of said particles but
exhibits in it* infrared absorption spectrum (as measured by Deleted
potassium bromide method) a substantially broader peak of absorption at
a wave number of 1750 cm-1, as compared with the sharp peak of
absorption exhibited by the orthorhombic crystalline substance of
Cefditoren pivoxil at a wave number of 1750 cm"1 in the infrared
absorption spectrum, and that the amorphous substance of Cefditoren
pivoxil (I) contained in said particles can be dissolved in an acidified water
containing hydrochloric acid (pH 1.2) at a solubility of at least 4 mg/ml of
Cefditoren pivoxil at 37°C and has a crystallographical stability such that
said amorphous Cefditoren pivoxil substance does not crystallize when
stored at 40°C for 4 months in a sealed container under dry conditions.
4. The composition as claimed in claim 3, wherein the central portion or core
portion of the respective particles which is lying under the surface layer of
the respective particles is formed from a homogeneous mixture of the
amorphous substance of Cefditoren pivoxfl wrth hydroxypropylmethyj
ceHulose, but the surface layer of sakl particles is formed from a
homogeneous mixture of the amorphous substance of Cefditoren pivoxil
with hydroxypropylmethyl ceNUose and also with hydroxypropyi cellulose
or methyl ceButose.
5. The composition as claimed in claim 3, wherein the central portion or core
portion of the respective particles which is lying under the surface layer of
the respective particles is formed from a homogeneous mixture of the
amorphous substance of Cefditoren pivoxil with hydroxypropyi ceHulose,
but the surface layer of said particles is formed from a homogeneous
mixture of the amorphous substance of Cefditoren pivoxil with
hydroxypropyi ceMulose and also with hydroxypropylmethyl cellulose or
methyl cellulose.
6. The composition as claimed in claim 3, wherein the central portion or core
portion of the respective particles which is lying under the surface layer of
the particles is formed from a homogeneous mixture of the amorphous
substance of Cefdftoren pivoxil with methyl cellulose, but the surface layer
of said particles is formed from a homogeneous mixture of the amorphous
substance of Cefdtoren pivoxil wrth methyl cellulose and also wrth
hydroxypropytmethyl ceHulose or hydroxypropyi cellulose.
7. The composition as claimed in damn 3, wherein the central portion or core
portion of the respective particles which is lying under the surface layer of
the particles is formed from a homogeneous mixture of the amorphous
substance of Cefditoren pivoxil with polyvinylpyrrolldone, but the surface
layer of said particles is formed from a homogeneous mixture of the
amorphous substance of Cefditoren pivoxil with polyvinylpyrrolidone and
also with hydroxypropylmethyl cellulose or hydroxypropyl cellulose or
methyl cellulose.
8. A process for the preparation of a yellow-colored powdery composition
consisting essentially of particles which each are formed of a
homogeneous mixture of a crystallographically stable, amorphous and
water-soluble substance of Cefditoren pivoxil with a water-soluble high-
molecular weight aciditive, and which particles have a uniform, internal
texture within each particle, wherein the process comprises a step of
dissolving an orthorhombic crystalline substance of Cefditoren pivoxil in an
acidic aqueous solution which contains a water-soluble high-molecular
weight aciditive made of either a water-solubilized derivative of cellulose
as chosen from hydroxypropylmethyl cellulose, hydroxypropylmethyl
cellulose phthalate, hydroxypropyl cellulose and methyl cellulose and a
pharmaceutically acceptable alkali metal salt or alkaline earth metal salt of
carboxymethyl cellulose, or pluran, carrageenan, polyvinylpyrrolldone or
an alginic acid ester of polypropylene glycol dissolved at a concentration
of 0.05% to 1% (weight/weight basis), and said acidic aqueous solution
also contains hydrochloric acid, phosphoric acid, sulfuric acid, acetic acid,
propionic acid or butyric acid at a concentration of 0.1N-12N of the acid,
so that the amount of Cefditoren pivoxil dissolved in said acidic aqueous
solution is in the range of 10 times to 130 times based on the entire weight
of said water-soluble high-molecular weight aciditive contained in said
acidic aqueous solution, resulting in an acidic aqueous solution containing
Cefditoren pivoxil, the water-soluble high-molecular weight aciditive and the
acid dissolved therein, a step of subsequently neutralizing the acidic aqueous
solution by aciding slowly thereto an aqueous solution selected from the group
consisting of an aqueous solution of sodium or potassium hydroxide, an
aqueous solution of sodium or potassium hydrogen carbonate, an aqueous
solution of sodium or potassium carbonate and an aqueous solution of
ammonium hydroxide, singly or in combination, while maintaining said acidic
aqueous solution at a temperature of 10°C or below under stirring, and with
the amount of said basic sodium or potassium compound or ammonium
hydroxide to be acided to said acidic aqueous solution being so adjusted that
the resulting reaction solution after the neutralization has a pH value of 6.5-
7.1, and a step of continuing during the neutralization reaction the stirring of
the aqueous solution containing Cefditoren pivoxil at a temperature of 10°C or
below, to bring about co-precipitation of Cefditoren pivoxil and the water-
soluble high-molecular weight aciditive simultaneously from the aqueous
solution, a step of collecting by filtration or cenfrifugation, the deposited
precipitate from the resulting neutralization reaction mixture, a step of
washing the collected precipitate with an aqueous solution of a water-soluble
high-molecular weight aciditive made of the same substance as that of the
first-mentioned water-soluble high-molecular weight aciditive and containing
said additive dissolved in said solution at a concentration of 0.5%-10%
(weight/weight basis), while at least a portion of said water-soluble high-
moleculer weight aciditive used in the washing aqueous solution is transferred
from the washing aqueous solution of the water-soluble high-molecular weight
aciditive onto the surfaces of the particles of said precipitate, and a step of
then drying the washed precipitate, to afford the yellow-colored powdery
composition consisting essentially of the particles each formed of the
homogeneous mixture of the crystallographically stable, amorphous and
water-soluble substance of Cefditoren pivoxil with the above-mentioned
water-soluble high-molecular weight aciditive present in a proportion of 0.5%-
5% based on the weight of the Cefditoren pivoxil substance.
9. The process as claimed in claim 8, which process comprises a step of
dissolving the orthorhombic substance of Cefditoren pivoxil in an acidic
aqueous solution which contains a water-soluble high-molecular weight
aciditive chosen from hydroxypropylmethyl cellulose, hydroxypropyl
cellulose, methyl cellulose and polyvinylpyrrolidone dissolved at a
concentration of 0.05% to 1% (weight/weight basis) and which acidic
aqueous solution also contains hydrochloric acid or phosphoric acid at a
concentration of 0.5N-2.0N of the acid, so that the amount of Cefditoren
pivoxil dissolved in said acidic aqueous solution is in a range of 10 times
to 100 times based on the entire weight of said water-soluble high-
molecular weight aciditive contained in said acidic aqueous solution, and
so that there is prepared an acidic aqueous solution containing Cefditoren
pivoxil, the water-soluble high-molecular aciditive and the acid dissolved
therein, a step of subsequently neutralizing the said acidic aqueous
solution containing Cefditoren pivoxil, by aciding slowly thereto a 1N-2N
aqueous sodium hydroxide solution and/or a 1N-2N aqueous sodium
hydrogen carbonate solution, or by aciding slowly thereto a 1N-2N
aqueous ammonium hydroxide solution, while maintaining said acidic
aqueous solution at a temperature of 5°C or below under stirring, until
said acidic aqueous solution is neutralized to a pH value of 6.5-7.0, a step
of continuing during the neutralization reaction the stirring of the resulting
neutralization reaction mixture at a temperature of 5°C or below, to bring
about co-precipitation of Cefditoren pivoxil and the water-soluble high-
molecular weight aciditive simultaneously from said aqueous solution, a
step of collecting the deposited precipitate from the resulting neutralization
reaction mixture, a step of washing the collected precipitate with an
aqueous solution of a water-soluble high-molecular weight aciditive made
of the same substance as that of the first-mentioned water-soluble high-
molecular weight aciditive and containing said aciditive dissolved in said
solution at a concentration of 0.5%-10% (weight/weight basis), and a step
of then drying the washed precipitate, to afford the yellow-colored powdery
composition consisting essentially of the particles each formed of a
homogeneous mixture of the amorphous substance of Cefditoren pivoxil
with the above-mentioned water-soluble high-molecular aciditive present in
a proportion of 1%-3% based on the weight of the Cefditoren pivoxil
substance.
10.The process for the preparation of a yellow-colored powdery composition as clamied in claim 1
consisting essentially of particles which each comprise mixtures of a
crystallographically stable, amorphous and water-soluble substance of
Cefditoren pivoxil with water-soluble high-molecular weight aciditive or
aciditives, wherein said particles have a uniform, internal texture within
each particle, wherein the process comprises a step of dissolving an
orthorhombic substance of Cefditoren pivoxil in an acidic aqueous solution
which contains a first water-soluble high-molecular weight aciditive made
of either a water-solubilized derivative of cellulose as chosen from
hydroxypropylmethyl cellulose, hydroxypropylmethyl cellulose phthalete,
hydroxypropyl cellulose and methyl cellulose and a pharmaceutically
acceptable alkali metal salt or alkaline earth metal salt of carboxymethyl
cellulose, or pluran, carrageenan, polyvinylpyrrolidone or an alginic acid
ester of polypropylene glycol dissolved at a concentration of 0.05%-1%
(weight/weight basis) and wherein said acidic aqueous solution also
contains hydrochloric acid, phosphoric acid, sulfuric acid, acetic acid,
propionic acid or butyric acid at a concentration of 0.1N-12N of the acid,
so that the amount of Cefditoren pivoxil dissolved in said acidic aqueous
solution is in a range of 10 times to 130 times based on the whole weight
of said first water-soluble high-molecular weight aciditive contained in said
acidic aqueous solution, resulting in an acidic aqueous solution containing
Cefditoren pivoxil, the water-soluble high-molecular weight aciditive and
the acid dissolved therein, a step of subsequently neutralizing the said
acidic aqueous solution, by aciding slowly thereto an aqueous solution
selected from the group consisting of an aqueous solution of sodium or
potassium hydroxide, an aqueous solution of sodium or potassium
hydrogen carbonate and an aqueous solution of sodium or potassium
carbonate, singly or in combination, or by adding slowly thereto an
aqueous solution of ammonium hydroxide, while maintaining said acidic
aqueous solution at a temperature of 10°C or below under stirring, and
with the amount of the basic sodium or potassium compound or
ammonium hydroxide to be acided to said acidic aqueous solution
adjusted so that the reaction solution after the neutralization has a pH
value of 6.5-7.1, a step of continuing during the neutralization reaction the
stirring of the aqueous solution containing Cefditoren pivoxil at a
temperature of 10°C or below, to bring about co-precipitation of
Cefditoren pivoxil and the first water-soluble high-molecular weight
aciditive simultaneously from the aqueous solution, a step of collecting by
filtration or centrifugation the precipitate from the resulting neutralization
reaction mixture, a step of washing the collected precipitate with an
aqueous solution which contains a second, water-soluble high-molecular
weight additive made of a substance different from the above-mentioned
first, water-soluble high-molecular weight aciditive contained in said acidic
aqueous solution containing Cefditoren pivoxil, and which aqueous
solution is containing said second high molecular weight additive
dissolved therein at a concentration of 0.5%-10% (weight/weight basis),
while at least a portion of said second water-soluble high-molecular weight
aciditive used in the washing aqueous solution is transferred from the
washing aqueous solution of the second water-soluble high-molecular
weight aciditive onto the surfaces of the particles of the precipitate, and. a
step of then drying the washed precipitate, to afford the yellow-colored
powdery composition consisting essentially of such particles which each
contain Cefditoren pivoxil, and of which the central portion or core portion
of each particle is formed only from a homogeneous mixture of the
crystallographically stable, amorphous and water-soluble substance of
Cefditoren pivoxil with the first water-soluble high-molecular weight
aciditive present in a proportion of 0.5%-5% based on the weight of said
Cefditoren pivoxil substance, and of which the surface layer of each
particle is formed from a homogeneous mixture of the crystallographically
stable, amorphous and water-soluble substance of Cefditoren pivoxil with
said first water-soluble high-molecular weight aciditive and also with said
second water-soluble high-molecular weight aciditive.
11.The process as claimed in claim which process comprises a step of
> dissolving the orthorhombic substance of Cefditoren pivoxil in an acidic
aqueous solution which contains a water-soluble high-molecular weight
aciditive as chosen from hydroxypropylmethyl cellulose, hydroxypropyl
cellulose, methyl cellulose and polyvinylpyrrolidone dissolved at a
concentration of 0.05%-1% (weight/weight basis) and which acidic
aqueous solution also contains hydrochloric acid or phosphoric acid at a
concentration of 0.5N-2.0N of the acid, so that the amount of Cefditoren
pivoxil dissolved in the acidic aqueous solution is in a range of 10 times to
100 times based on the entire weight of said first water-soluble high-
molecular weight aciditive contained In said acidic aqueous solution,
resulting in an acidic aqueous solution containing Cefditoren pivoxil, the
water-soluble high-molecular weight aciditive and the said acid dissolved
therein, a step of subsequently neutralizing the acidic aqueous solution
containing Cefditoren pivoxil, by aciding slowly thereto an aqueous 1N-2N
sodium hydroxide solution and/or an aqueous 1N-2N sodium hydrogen
carbonate solution or by aciding slowly thereto an aqueous 1N-2N ammonium
hydroxide solution, while maintaining the acidic aqueous solution at a
temperature of 5°C or below under stirring, until the acidic aqueous solution is
neutralized to a pH value of 6.5-7.0, a step of continuing the stirring of the
neutralization reaction mixture at a temperature of 5°C or below during the
neutralization reaction, to bring about the co-precipitation of Cefditoren pivoxil
and said first water-soluble high-molecular weight aciditive simultaneously
from the aqueous solution, a step of collecting the deposited precipitate from
the resulting neutralization reaction mixture, a step of washing the collected
precipitate with an aqueous solution which contains, as the second water-
soluble high-molecular weight aciditive made of a substance different from
the above-mentioned first water-soluble high-molecular weight aciditive, a
water-soluble high-molecular weight aciditive chosen from
hydroxypropyimethyl cellulose, hydroxypropyl cellulose, methyl cellulose and
polyvinylpyrrolidone, and which aqueous solution contains said second high-
molecular weight aciditive dissolved therein at a concentration of 0.5%-10%
(weight/weight basis), while at least a portion of the second water-soluble
high-molecular weight aciditive used in the washing aqueous solution is
transferred from said aqueous solution of the second water-soluble high-
molecular weight aciditive onto the surfaces of the particles of the precipitate,
and a step of then drying the washed precipitate, to afford the yellow-colored
powdery composition consisting essentially of such particles of which the
central portion or core portion of each particle is formed only from a
homogeneous mixture of the amorphous substance of Cefditoren pivoxil with
said first water-soluble high-molecular weight aciditive, and of which the
surface layer of each particle is formed from a homogeneous mixture of the
amorphous substance of Cefditoren pivoxil with said first water-soluble high-
molecular weight aciditive and also with said second water-soluble high-
molecular weight aciditive.
Processes are provided for the preparation of orally administrable, yellow and
powdery compositions essentially consisting of particles composed of a
homogeneous mixture of an amorphous Cefditoren pivoxil substance with a
water soluble high-molecular additive. These compositions can be produced by
dissolving crystalline Cefditoren pivoxil substance and the water-soluble high-
molecular aciditive in an aqueous solution of an acid, then neutralizing the
resultant solution, to co-precipitate the product, and drying the thus precipitated
product, followed by recovering the product in the form of the above-mentioned
particles.

Documents:

in-pct-2000-00100-kol-granted-abstract.pdf

in-pct-2000-00100-kol-granted-claims.pdf

in-pct-2000-00100-kol-granted-correspondence.pdf

in-pct-2000-00100-kol-granted-description (complete).pdf

in-pct-2000-00100-kol-granted-drawings.pdf

in-pct-2000-00100-kol-granted-form 1.pdf

in-pct-2000-00100-kol-granted-form 18.pdf

in-pct-2000-00100-kol-granted-form 2.pdf

in-pct-2000-00100-kol-granted-form 26.pdf

in-pct-2000-00100-kol-granted-form 3.pdf

in-pct-2000-00100-kol-granted-form 5.pdf

in-pct-2000-00100-kol-granted-letter patent.pdf

in-pct-2000-00100-kol-granted-priority document.pdf

in-pct-2000-00100-kol-granted-reply to examination report.pdf

in-pct-2000-00100-kol-granted-specification.pdf

IN-PCT-2000-100-KOL-(05-01-2012)-CORRESPONDENCE.pdf

IN-PCT-2000-100-KOL-(05-01-2012)-ENGLISH TRANSLATION.pdf

IN-PCT-2000-100-KOL-(05-01-2012)-FORM-13.pdf

IN-PCT-2000-100-KOL-(05-01-2012)-PA-CERTIFIED COPIES.pdf

IN-PCT-2000-100-KOL-FORM-27.pdf


« Previous Patent
Next Patent »
Patent Number 217460
Indian Patent Application Number IN/PCT/2000/100/KOL
PG Journal Number 13/2008
Publication Date 28-Mar-2008
Grant Date 26-Mar-2008
Date of Filing 02-Jun-2000
Name of Patentee MEIJI SEIKA KAISHA LTD
Applicant Address 4-16 KYOBASHI 2-CHOME, CHUO-KU, TOKYO, 104-0031, JAPAN.
Inventors:
# Inventor's Name Inventor's Address
1 ONODERA MASAHIRO C/O. PHARMACEUTICAL TECHNOLOGY LABORATORIES, MEIJI SEIKA KAISAH LTD., 788, KAYAMA, ODAWARA-SHI, KANAGAWA 250-0852, JAPAN.
2 SUKEGAWA MASAMICHI -DO-
3 YASUI KIYOSHI -DO-
4 WATANABE TATSUO -DO-
5 SATO TOYOMI -DO-
6 MURAI YASUSHI -DO-
7 IINUMA KATSUHARU -DO-
PCT International Classification Number A61K47/38,C07D501/24
PCT International Application Number PCT/JP99/00020
PCT International Filing date 1999-01-07
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 10/1920 1998-01-07 Japan